THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY. furp.org, nonprofit organization profile, tax years 2010–2025. https://furp.org/org/the-wistar-institute-of-anatomy-and-biology-236434390. Retrieved 2026-11-04.
APA furp.org. (n.d.). THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY [Nonprofit organization profile; tax years 2010–2025]. Retrieved November 4, 2026, from https://furp.org/org/the-wistar-institute-of-anatomy-and-biology-236434390
MLA “THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY.” furp.org, tax years 2010–2025, https://furp.org/org/the-wistar-institute-of-anatomy-and-biology-236434390. Accessed 4 Nov. 2026.
Retrieved 2026-11-04; covers tax years 2010–2025. Data: furp.org, CC BY 4.0.
2025 · Form 990 · revenue $77.3M · expenses $89.9M · assets $419.1M
- Also known as
- BIOLOGY
- EIN
- 23-6434390
- Address
- 3601 SPRUCE ST, PHILADELPHIA, PA 19104-4205
- Website
- WWW.WISTAR.ORG
- NTEE code
- H300
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- November 1946 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Public charity supported by the public (170(b)(1)(a)(vi))
- Cross-check
- ProPublica Nonprofit Explorer
Mission
THE MISSION OF THE WISTAR INSTITUTE IS TO MARSHAL THE TALENTS OF OUTSTANDING SCIENTISTS THROUGH A HIGHLY ENABLED CULTURE OF BIOMEDICAL COLLABORATION AND INNOVATION IN ORDER TO SOLVE SOME OF THE WORLD'S MOST CHALLENGING AND IMPORTANT PROBLEMS IN THE FIELD OF CANCER AND IMMUNOLOGY, AND PRODUCE GROUND-BREAKING ADVANCES IN WORLD HEALTH. CONSISTENT WITH A PIONEERING LEGACY OF LEADERSHIP IN NOT-FOR-PROFIT BIOMEDICAL RESEARCH AND A TRACK-RECORD OF LIFE-SAVING CONTRIBUTIONS IN IMMUNOLOGY AND CELL BIOLOGY, THE WISTAR INSTITUTE AIMS TO PURSUE NOVEL AND COURAGEOUS RESEARCH PATHS TO LIFE SCIENCE DISCOVERY, AND TO ACCELERATE/POTENTIATE THE IMPACT OF THOSE DISCOVERIES BY SHORTENING THE PATH FROM BENCH TO BEDSIDE.
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
39 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Dario Altieri Md | PRESIDENT & CEO, DIRECTOR OF WISTAR CANCER CENTER | 2010-2025 | $758,347 | $8,574,742 | 1 |
| David B Weiner | EXECUTIVE VICE PRESIDENT | 2017-2025 | $570,149 | $4,387,958 | 1 |
| Luis Montaner | PROFESSOR VP, SCIENTIFIC OPERATIONS | 2017-2025 | $595,164 | $4,237,404 | 1 |
| Meenhard Herlyn | PROFESSOR | 2010-2025 | $377,098 | $4,196,003 | 1 |
| Heather A Steinman | VP FOR BUSINESS DEVELOP & E. D. TECH | 2015-2025 | $401,752 | $3,411,743 | 1 |
| Joann Mendel | VICE PRESIDENT, HUMAN RESOURCES | 2018-2025 | $290,872 | $2,010,183 | 1 |
| Paul Lieberman | PROFESSOR | 2013-2025 | $426,346 | $1,379,596 | 1 |
| Gelvina Stevenson | VP GEN COUNSEL, SECRETARY & GOVERNMENT RELATIONS | 2023-2025 | $457,213 | $1,291,956 | 1 |
| Michael Criscuolo | VP, DEVELOPMENT | 2023-2025 | $352,106 | $1,003,629 | 1 |
| Maureen Murphy | PROFESSOR | 2023-2025 | $333,696 | $959,245 | 1 |
| Constantine Stoios | CHIEF FINANCIAL OFFICER | 2024-2025 | $389,476 | $752,070 | 1 |
| Chengyu Liang | PROFESSOR | 2024-2025 | $339,719 | $668,578 | 1 |
| Jeffrey Fahnoe | CHIEF INFORMATION OFFICER | 2024-2025 | $319,027 | $620,968 | 1 |
| Peter Scarpati | VP OPERATIONS | 2024-2025 | $303,064 | $570,386 | 1 |
| Joseph Salvino | PROFESSOR | 2025 | $331,897 | $331,897 | 1 |
| Russel Kaufman MD (former) | President and CEO until March, 2015 | 2010-2015 | $739,695 | $4,297,695 | 1 |
| David Speicher (former) | PROFESSOR | 2010-2022 | $316,928 | $3,116,550 | 1 |
| Hildegund Ertl (former) | PROFESSOR | 2010-2023 | $311,794 | $2,771,938 | 1 |
| Joseph Trainor (former) | CHIEF FINANCIAL OFFICER | 2013-2022 | $328,011 | $2,482,321 | 3 |
| Frank Rauscher (former) | Professor | 2011-2019 | $320,241 | $2,248,658 | 1 |
| Jennifer Evans Stacey (former) | VICE PRESIDENT, GEN COUNSEL, SEC & GOV RELATIONS | 2017-2021 | $349,916 | $1,834,649 | 1 |
| Dmitry Gabrilovich (former) | Professor | 2014-2019 | $390,539 | $1,722,331 | 1 |
| Anita Pepper (former) | VP, INSTITUTION ADV (TERM 07/2022) | 2015-2022 | $189,873 | $1,516,523 | 1 |
| Elizabeth O'Brien (former) | Vice President | 2010-2014 | $296,000 | $1,485,000 | 1 |
| Rugang Zhang (former) | PROFESSOR | 2019-2022 | $304,864 | $1,279,894 | 1 |
| Alan Stiles (former) | Chief Operating Officer | 2012-2015 | $326,391 | $1,078,391 | 1 |
| Larry Keinath (former) | Vice President | 2010-2013 | $174,000 | $1,067,000 | 1 |
| Ellen Pure PhD (former) | Professor | 2010-2012 | $253,000 | $745,000 | 1 |
| Peter Corrado (former) | Vice President | 2010-2012 | $250,000 | $729,000 | 1 |
| Meenhard Herlyn DVM DSc (former) | Professor | 2014-2015 | $290,227 | $583,227 | 1 |
| Elizabeth OBrien Esquire (former) | VP for Legal and External Affairs | 2015 | $327,827 | $327,827 | 1 |
| Michele Schiavoni (former) | VP COMMUNICATIONS & MARKETING | 2024 | $298,933 | $298,933 | 1 |
| Eden A Graber (former) | Vice President for Development and Marketing | 2014 | $297,000 | $297,000 | 1 |
| George Hobbs (former) | Vice President | 2013-2014 | $71,000 | $249,000 | 1 |
| Ramin Shiekhattar PhD (former) | Professor | 2010 | $249,000 | $249,000 | 1 |
| Clara Stevenson Rodriguez (former) | VP GEN COUNSIL & GOV RELATIONS (START ?) | 2022 | $208,178 | $208,178 | 1 |
| James Verzella (former) | Construction Project Executive | 2014 | $191,000 | $191,000 | 1 |
| Joseph Trainor Until May 2023 (former) | CHIEF FINANCIAL OFFICER | 2023 | $149,406 | $149,406 | 1 |
| Constantine Stoios Began Sep 2023 (former) | CHIEF FINANCIAL OFFICER | 2023 | $104,992 | $104,992 | 1 |
Officers and directors, no compensation reported
86 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Ira Brind | TRUSTEE | 2010-2025 | 1 | $0 reported | 13 |
| Robert H Rock | TRUSTEE | 2010-2025 | 1 | $0 reported | 4 |
| Gerald B Rorer | TRUSTEE | 2010-2025 | 1 | $0 reported | 2 |
| Daniel K Fitzpatrick | TRUSTEE (LEFT MAY 2025) | 2011-2025 | 1 | $0 reported | 18 |
| Richard M Horowitz | TRUSTEE - BOARD CHAIR | 2010-2025 | 4 | $0 reported | 1 |
| Steven V Abramson | TRUSTEE | 2020-2025 | 1 | $0 reported | 1 |
| Elizabeth Mckee Anderson | TRUSTEE | 2011-2025 | 2 | $0 reported | 1 |
| Max Berger | TRUSTEE | 2024-2025 | 1 | $0 reported | 1 |
| Douglas S Briggs | TRUSTEE | 2015-2025 | 1 | $0 reported | 1 |
| Ronald Caplan | TRUSTEE | 2010-2025 | 2 | $0 reported | 3 |
| Arthur Dantchik | TRUSTEE | 2019-2025 | 1 | $0 reported | 1 |
| Susan B Dillon Phd | TRUSTEE - VICE CHAIR | 2017-2025 | 1 | $0 reported | 1 |
| Joseph A Goldblum | TRUSTEE | 2012-2025 | 2 | $0 reported | 1 |
| Perry A Lerner | TRUSTEE | 2014-2025 | 1 | $0 reported | 1 |
| Susan S Mcdonald Phd | TRUSTEE | 2010-2025 | 2 | $0 reported | 1 |
| Abraham L Morris | TRUSTEE | 2012-2025 | 1 | $0 reported | 1 |
| Patrick Oates | TRUSTEE | 2024-2025 | 1 | $0 reported | 1 |
| Arthur M Pappas | TRUSTEE | 2012-2025 | 1 | $0 reported | 1 |
| Helen P Pudlin Esq | TRUSTEE | 2010-2025 | 1 | $0 reported | 1 |
| Samuel V Rhoads | TRUSTEE | 2010-2025 | 1 | $0 reported | 1 |
| Aleister Saunders | TRUSTEE | 2024-2025 | 1 | $0 reported | 1 |
| Adele K Schaeffer | TRUSTEE (LEFT SEPT 2025) | 2010-2025 | 1 | $0 reported | 5 |
| Milton S Schneider | TRUSTEE | 2010-2025 | 1 | $0 reported | 1 |
| Squire Servance | TRUSTEE (LEFT DEC 2025) | 2022-2025 | 1 | $0 reported | 1 |
| William A Slaughter | TRUSTEE | 2013-2025 | 1 | $0 reported | 1 |
| Joy Taylor | TRUSTEE | 2023-2025 | 1 | $0 reported | 1 |
| Sozi Tulante | TRUSTEE | 2024-2025 | 1 | $0 reported | 1 |
| Edward Ziff Phd | TRUSTEE | 2010-2025 | 1 | $0 reported | 1 |
| Catherine Creese | TRUSTEE (JOINED JAN 2025) | 2025 | 1 | $0 reported | 1 |
| Carolyn Magill | TRUSTEE | 2025 | 1 | $0 reported | 1 |
| Charles Cairns | TRUSTEE | 2025 | 1 | $0 reported | 1 |
| Elliot Norry | TRUSTEE | 2025 | 1 | $0 reported | 1 |
| James Lovett | TRUSTEE (ELECTED DEC 2025) | 2017-2025 | 1 | $0 reported | 4 |
| Joshua Friedman | TRUSTEE (ELECTED MAR 2025) | 2025 | 1 | $0 reported | 1 |
| David Krupnick | TRUSTEE | 2025 | 1 | $0 reported | 1 |
| Elliot Menschik | TRUSTEE (JUNE TO DEC 2025) | 2025 | 1 | $0 reported | 1 |
| Catherine Creese Elected Dec 2024 (former) | TRUSTEE | 2024 | 1 | $0 reported | 1 |
| Carolyn Magill Elected Dec 2024 (former) | TRUSTEE | 2024 | 1 | $0 reported | 1 |
| Charles Cairns Elected Dec 2024 (former) | TRUSTEE | 2024 | 1 | $0 reported | 1 |
| Elliot Norry Elected Mar 2024 (former) | TRUSTEE | 2024 | 1 | $0 reported | 1 |
| John Fry Left Nov 2024 (former) | TRUSTEE | 2024 | 1 | $0 reported | 1 |
| John Fry (former) | TRUSTEE | 2017-2023 | 1 | $0 reported | 22 |
| Max Berger Appointed Dec 2023 (former) | TRUSTEE | 2023 | 1 | $0 reported | 1 |
| Scott Cooper Until Sep 2023 (former) | TRUSTEE | 2023 | 1 | $0 reported | 1 |
| Brian H Dovey Until Aug 2023 (former) | TRUSTEE | 2023 | 2 | $0 reported | 1 |
| Patrick Oates Appointed Sep 2023 (former) | TRUSTEE | 2023 | 1 | $0 reported | 1 |
| Aleister Saunders Appointed Sep 202 (former) | TRUSTEE | 2023 | 1 | $0 reported | 1 |
| Sozi Tulante Appointed Mar 2023 (former) | TRUSTEE | 2023 | 1 | $0 reported | 1 |
| Daniel H Wheeler Until Jul 2023 (former) | TRUSTEE | 2023 | 2 | $0 reported | 1 |
| Scott Cooper Phd (former) | TRUSTEE | 2020-2022 | 1 | $0 reported | 4 |
| Steven V Abramnson (former) | TRUSTEE | 2021-2022 | 1 | $0 reported | 1 |
| Brian H Dovey (former) | TRUSTEE | 2010-2022 | 2 | $0 reported | 1 |
| Kendra Eager (former) | TRUSTEE (06/2022 - 09/2022) | 2022 | 1 | $0 reported | 1 |
| Richard G Phillips Jr (former) | TRUSTEE | 2020-2022 | 1 | $0 reported | 1 |
| Daniel H Wheeler (former) | TRUSTEE | 2010-2022 | 2 | $0 reported | 1 |
| Wendell Pritchett (former) | TRUSTEE | 2017-2021 | 1 | $0 reported | 4 |
| Robert Fox (former) | Trustee | 2010-2020 | 2 | $0 reported | 3 |
| Judith E Soltz (former) | Trustee (until 9/2020) | 2010-2020 | 1 | $0 reported | 2 |
| Morton Collins PhD (former) | Trustee | 2017-2020 | 1 | $0 reported | 1 |
| Herbert Kean MD (former) | Trustee | 2010-2020 | 0 | $0 reported | 1 |
| Maida Milone (former) | Trustee | 2010-2020 | 1 | $0 reported | 1 |
| Cavan Redmond (former) | Trustee | 2017-2019 | 1 | $0 reported | 1 |
| L Patrick Gage PhD (former) | Trustee | 2013-2018 | 2 | $0 reported | 1 |
| Vincent Price (former) | Trustee (until July 2017) | 2010-2017 | 1 | $0 reported | 3 |
| George W Gephart (former) | Trustee (until June 2017) | 2015-2017 | 1 | $0 reported | 1 |
| Albert Ominsky Esq (former) | Trustee | 2010-2017 | 1 | $0 reported | 1 |
| Paul J Schmitt (former) | Trustee | 2010-2017 | 1 | $0 reported | 1 |
| David V Wachs (former) | Trustee | 2010-2017 | 1 | $0 reported | 1 |
| Van Billet (former) | Trustee | 2012-2015 | 0 | $0 reported | 1 |
| Robert S Blank (former) | Trustee | 2010-2015 | 0 | $0 reported | 2 |
| Judith S Soltz (former) | Trustee | 2015 | 1 | $0 reported | 1 |
| Mark L Greenberg (former) | PhD (Term expired in February 2015) | 2013-2015 | 1 | $0 reported | 2 |
| Douglas D Briggs (former) | Trustee | 2010-2014 | 1 | $0 reported | 1 |
| Faye Olivieri-Kozich (former) | Trustee | 2010-2013 | 1 | $0 reported | 1 |
| Seymour S Preston Iii (former) | Treasurer | 2010-2012 | 1 | $0 reported | 2 |
| I Wistar Morris (former) | Trustee | 2011-2012 | 1 | $0 reported | 1 |
| Lawrence V Stein (former) | Trustee | 2011-2012 | 1 | $0 reported | 1 |
| Dani Bolognesi PhD (former) | Trustee | 2010-2011 | 0 | $0 reported | 1 |
| Hilary Koprowski MD (former) | Trustee | 2010-2011 | 0 | $0 reported | 1 |
| Dan W Matthias (former) | Trustee | 2010-2011 | 0 | $0 reported | 1 |
| Arthur L Stokes MD (former) | Trustee | 2010-2011 | 0 | $0 reported | 1 |
| Kevin M Tucker (former) | Trustee | 2010-2011 | 0 | $0 reported | 1 |
| Doris Taxin (former) | Secretary | 2010 | 0 | $0 reported | 1 |
| Richard E Fitzpatrick (former) | Trustee | 2010 | 0 | $0 reported | 1 |
| Dr Gail Hearn (former) | Trustee | 2010 | 0 | $0 reported | 2 |
| George J Vergis PhD (former) | Trustee | 2010 | 0 | $0 reported | 1 |
People by year
2025 · 51 people listed · 15 paid, $6.2M · 377 employees · 73 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DARIO ALTIERI MD | PRESIDENT & CEO, DIRECTOR OF WISTAR CANCER CENTER | 55 | $701,631 | $0 | $56,716 | $758,347 | 1 |
| LUIS MONTANER | PROFESSOR VP, SCIENTIFIC OPERATIONS | 55 | $518,220 | $0 | $76,944 | $595,164 | 1 |
| DAVID B WEINER | EXECUTIVE VICE PRESIDENT | 55 | $497,122 | $0 | $73,027 | $570,149 | 1 |
| GELVINA STEVENSON | VP GEN COUNSEL, SECRETARY & GOVERNMENT RELATIONS | 55 | $411,550 | $0 | $45,663 | $457,213 | 1 |
| PAUL LIEBERMAN | PROFESSOR | 55 | $355,586 | $0 | $70,760 | $426,346 | 1 |
| HEATHER A STEINMAN | VP FOR BUSINESS DEVELOP & E. D. TECH | 55 | $360,818 | $0 | $40,934 | $401,752 | 1 |
| CONSTANTINE STOIOS | CHIEF FINANCIAL OFFICER | 55 | $316,654 | $0 | $72,822 | $389,476 | 1 |
| MEENHARD HERLYN | PROFESSOR | 55 | $306,752 | $0 | $70,346 | $377,098 | 1 |
| MICHAEL CRISCUOLO | VP, DEVELOPMENT | 55 | $314,962 | $0 | $37,144 | $352,106 | 1 |
| CHENGYU LIANG | PROFESSOR | 55 | $267,432 | $0 | $72,287 | $339,719 | 1 |
| MAUREEN MURPHY | PROFESSOR | 55 | $271,408 | $0 | $62,288 | $333,696 | 1 |
| JOSEPH SALVINO | PROFESSOR | 55 | $292,613 | $0 | $39,284 | $331,897 | 1 |
| JEFFREY FAHNOE | CHIEF INFORMATION OFFICER | 55 | $271,238 | $0 | $47,789 | $319,027 | 1 |
| PETER SCARPATI | VP OPERATIONS | 55 | $266,748 | $0 | $36,316 | $303,064 | 1 |
| JOANN MENDEL | VICE PRESIDENT, HUMAN RESOURCES | 55 | $248,283 | $0 | $42,589 | $290,872 | 1 |
| RICHARD M HOROWITZ | TRUSTEE - BOARD CHAIR | 4 | $0 | $0 | $0 | $0 | 1 |
| SUSAN B DILLON PHD | TRUSTEE - VICE CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| STEVEN V ABRAMSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ELIZABETH MCKEE ANDERSON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MAX BERGER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DOUGLAS S BRIGGS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| IRA BRIND | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 13 |
| RONALD CAPLAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| CATHERINE CREESE | TRUSTEE (JOINED JAN 2025) | 1 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR DANTCHIK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DANIEL K FITZPATRICK | TRUSTEE (LEFT MAY 2025) | 1 | $0 | $0 | $0 | $0 | 18 |
| JOSEPH A GOLDBLUM | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| PERRY A LERNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SUSAN S MCDONALD PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ABRAHAM L MORRIS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PATRICK OATES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR M PAPPAS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| HELEN P PUDLIN ESQ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAMUEL V RHOADS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT H ROCK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| GERALD B RORER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ALEISTER SAUNDERS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ADELE K SCHAEFFER | TRUSTEE (LEFT SEPT 2025) | 1 | $0 | $0 | $0 | $0 | 5 |
| MILTON S SCHNEIDER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SQUIRE SERVANCE | TRUSTEE (LEFT DEC 2025) | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM A SLAUGHTER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOY TAYLOR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SOZI TULANTE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CAROLYN MAGILL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| EDWARD ZIFF PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLES CAIRNS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ELLIOT NORRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JAMES LOVETT | TRUSTEE (ELECTED DEC 2025) | 1 | $0 | $0 | $0 | $0 | 4 |
| JOSHUA FRIEDMAN | TRUSTEE (ELECTED MAR 2025) | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID KRUPNICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ELLIOT MENSCHIK | TRUSTEE (JUNE TO DEC 2025) | 1 | $0 | $0 | $0 | $0 | 1 |
2024 · 48 people listed · 15 paid, $5.9M · 455 employees · 68 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DARIO ALTIERI MD | PRESIDENT & CEO, DIRECTOR | 55 | $722,629 | $0 | $54,792 | $777,421 | 1 |
| DAVID B WEINER | EXECUTIVE VICE PRESIDENT | 55 | $492,577 | $0 | $69,076 | $561,653 | 1 |
| LUIS MONTANER | PROFESSOR VP, SCIENTIFIC O | 55 | $452,720 | $0 | $73,256 | $525,976 | 1 |
| GELVINA STEVENSON | VP GEN COUNSEL, SECRETARY& | 55 | $388,759 | $0 | $43,897 | $432,656 | 1 |
| HEATHER A STEINMAN | VP FOR BUSINESS DEVELOP & | 55 | $347,749 | $0 | $40,300 | $388,049 | 1 |
| CONSTANTINE STOIOS | CHIEF FINANCIAL OFFICER | 55 | $295,997 | $0 | $66,597 | $362,594 | 1 |
| MEENHARD HERLYN | PROFESSOR | 55 | $298,624 | $0 | $62,520 | $361,144 | 1 |
| PAUL LIEBERMAN | PROFESSOR | 55 | $285,042 | $0 | $60,447 | $345,489 | 1 |
| MICHAEL CRISCUOLO | VP, DEVELOPMENT | 55 | $283,859 | $0 | $55,443 | $339,302 | 1 |
| CHENGYU LIANG | PROFESSOR | 55 | $261,764 | $0 | $67,095 | $328,859 | 1 |
| MAUREEN MURPHY | PROFESSOR | 55 | $260,169 | $0 | $57,945 | $318,114 | 1 |
| JEFFREY FAHNOE | CHIEF INFORMATION OFFICER | 55 | $256,958 | $0 | $44,983 | $301,941 | 1 |
| MICHELE SCHIAVONI | VP COMMUNICATIONS & MARKETING | 55 | $267,125 | $0 | $31,808 | $298,933 | 1 |
| JOANN MENDEL | VICE PRESIDENT, HUMAN RESO | 55 | $236,284 | $0 | $38,855 | $275,139 | 1 |
| PETER SCARPATI | VP OPERATIONS | 55 | $234,961 | $0 | $32,361 | $267,322 | 1 |
| RICHARD M HOROWITZ | TRUSTEE - BOARD CHAIR | 4 | $0 | $0 | $0 | $0 | 1 |
| STEVEN V ABRAMSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ELIZABETH MCKEE ANDERSON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MAX BERGER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DOUGLAS S BRIGGS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| IRA BRIND | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 13 |
| RONALD CAPLAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| CATHERINE CREESE ELECTED DEC 2024 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR DANTCHIK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SUSAN B DILLON PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DANIEL K FITZPATRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 18 |
| JOSEPH A GOLDBLUM | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| PERRY A LERNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SUSAN S MCDONALD PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ABRAHAM L MORRIS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PATRICK OATES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR M PAPPAS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| HELEN P PUDLIN ESQ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAMUEL V RHOADS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT H ROCK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| GERALD B RORER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ALEISTER SAUNDERS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ADELE K SCHAEFFER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| MILTON S SCHNEIDER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SQUIRE SERVANCE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM A SLAUGHTER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOY TAYLOR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SOZI TULANTE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CAROLYN MAGILL ELECTED DEC 2024 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| EDWARD ZIFF PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLES CAIRNS ELECTED DEC 2024 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ELLIOT NORRY ELECTED MAR 2024 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN FRY LEFT NOV 2024 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2023 · 45 people listed · 13 paid, $4.7M · 457 employees · 62 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DARIO ALTIERI MD | PRESIDENT & CEO, DIRECTOR WISTAR CANCER CENTER | 55 | $695,231 | $0 | $52,240 | $747,471 | 1 |
| DAVID B WEINER | EXECUTIVE VICE PRESIDENT | 55 | $474,053 | $0 | $63,822 | $537,875 | 1 |
| LUIS MONTANER | PROFESSOR VP, SCIENTIFIC OPERATIONS | 55 | $398,122 | $0 | $69,802 | $467,924 | 1 |
| GELVINA STEVENSON | VP GEN COUNSEL, SECRETARY& GOV RELATIONS | 55 | $361,859 | $0 | $40,228 | $402,087 | 1 |
| MEENHARD HERLYN | PROFESSOR | 55 | $314,306 | $0 | $65,935 | $380,241 | 1 |
| HEATHER A STEINMAN | VP FOR BUSINESS DEVELOP & ED TECH | 55 | $332,348 | $0 | $38,587 | $370,935 | 1 |
| PAUL LIEBERMAN | PROFESSOR | 55 | $275,087 | $0 | $57,674 | $332,761 | 1 |
| MICHAEL CRISCUOLO | VP, DEVELOPMENT | 55 | $253,281 | $0 | $58,940 | $312,221 | 1 |
| HILDEGUND ERTL | PROFESSOR | 55 | $267,406 | $0 | $44,388 | $311,794 | 1 |
| MAUREEN MURPHY | PROFESSOR | 55 | $252,407 | $0 | $55,028 | $307,435 | 1 |
| JOANN MENDEL | VICE PRESIDENT, HUMAN RESOURCES | 55 | $223,372 | $0 | $36,635 | $260,007 | 1 |
| JOSEPH TRAINOR UNTIL MAY 2023 | CHIEF FINANCIAL OFFICER | 55 | $130,191 | $0 | $19,215 | $149,406 | 1 |
| CONSTANTINE STOIOS BEGAN SEP 2023 | CHIEF FINANCIAL OFFICER | 55 | $89,474 | $0 | $15,518 | $104,992 | 1 |
| RICHARD M HOROWITZ | TRUSTEE - BOARD CHAIR | 4 | $0 | $0 | $0 | $0 | 1 |
| STEVEN V ABRAMSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ELIZABETH MCKEE ANDERSON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MAX BERGER APPOINTED DEC 2023 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DOUGLAS S BRIGGS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| IRA BRIND | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 13 |
| RONALD CAPLAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| SCOTT COOPER UNTIL SEP 2023 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR DANTCHIK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SUSAN B DILLON PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BRIAN H DOVEY UNTIL AUG 2023 | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| DANIEL K FITZPATRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 18 |
| JOHN FRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 22 |
| JOSEPH A GOLDBLUM | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| PERRY A LERNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SUSAN S MCDONALD PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ABRAHAM L MORRIS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PATRICK OATES APPOINTED SEP 2023 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR M PAPPAS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| HELEN P PUDLIN ESQ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SAMUEL V RHOADS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT H ROCK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| GERALD B RORER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ALEISTER SAUNDERS APPOINTED SEP 202 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ADELE K SCHAEFFER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| MILTON S SCHNEIDER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SQUIRE SERVANCE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM A SLAUGHTER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOY TAYLOR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SOZI TULANTE APPOINTED MAR 2023 | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DANIEL H WHEELER UNTIL JUL 2023 | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| EDWARD ZIFF PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2022 · 42 people listed · 12 paid, $4.2M · 435 employees · 46 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DARIO ALTIERI MD | PRESIDENT & CEO, DIRECTOR | 55 | $667,613 | $0 | $44,217 | $711,830 | 1 |
| DAVID B WEINER | EXECUTIVE VICE PRESIDENT | 55 | $447,009 | $0 | $60,813 | $507,822 | 1 |
| LUIS MONTANER | PROFESSOR VICE PRESIDENT, | 55 | $359,980 | $0 | $64,228 | $424,208 | 1 |
| HEATHER A STEINMAN | VP FOR BUSINESS DEVELOP & | 55 | $305,345 | $0 | $39,779 | $345,124 | 1 |
| MEENHARD HERLYN | PROFESSOR | 55 | $293,576 | $0 | $51,307 | $344,883 | 1 |
| JOSEPH TRAINOR | CHIEF FINANCIAL OFFICER | 55 | $279,107 | $0 | $48,904 | $328,011 | 3 |
| DAVID SPEICHER | PROFESSOR | 55 | $259,545 | $0 | $57,383 | $316,928 | 1 |
| RUGANG ZHANG | PROFESSOR | 55 | $269,338 | $0 | $35,526 | $304,864 | 1 |
| HILDEGUND ERTL | PROFESSOR | 55 | $256,492 | $0 | $42,311 | $298,803 | 1 |
| JOANN MENDEL | VICE PRESIDENT, HUMAN RESO | 55 | $208,654 | $0 | $36,210 | $244,864 | 1 |
| CLARA STEVENSON RODRIGUEZ | VP GEN COUNSIL & GOV RELATIONS (START ?) | 55 | $183,541 | $0 | $24,637 | $208,178 | 1 |
| ANITA PEPPER | VP, INSTITUTION ADV (TERM 07/2022) | 55 | $167,741 | $0 | $22,132 | $189,873 | 1 |
| STEVEN V ABRAMNSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ELIZABETH MCKEE ANDERSON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| DOUGLAS S BRIGGS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| IRA BRIND | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 13 |
| RONALD CAPLAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| SCOTT COOPER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| ARTHUR DANTCHIK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SUSAN B DILLON PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BRIAN H DOVEY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| KENDRA EAGER | TRUSTEE (06/2022 - 09/2022) | 1 | $0 | $0 | $0 | $0 | 1 |
| DANIEL K FITZPATRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 18 |
| JOHN FRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 22 |
| JOSEPH A GOLDBLUM | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| RICHARD M HOROWITZ | TRUSTEE - BOARD VICE CHAIR | 4 | $0 | $0 | $0 | $0 | 1 |
| PERRY A LERNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JAMES W LOVETT | TRUSTEE (TERM 12/2022) | 2 | $0 | $0 | $0 | $0 | 4 |
| SUSAN S MCDONALD PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ABRAHAM L MORRIS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR M PAPPAS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD G PHILLIPS JR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| HELEN P PUDLIN ESQ | TRUSTEE - BOARD CHAIR | 4 | $0 | $0 | $0 | $0 | 1 |
| SAMUEL V RHOADS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT H ROCK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| GERALD B RORER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ADELE K SCHAEFFER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| MILTON S SCHNEIDER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SQUIRE SERVANCE | TRUSTEE (START 12/2022) | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM A SLAUGHTER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DANIEL H WHEELER | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| EDWARD ZIFF PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2021 · 41 people listed · 12 paid, $4.4M · 386 employees · 46 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DARIO ALTIERI MD | PRESIDENT & CEO, DIRECTOR OF WISTAR CANCER CENTER | 55 | $643,096 | $0 | $41,678 | $684,774 | 1 |
| DAVID B WEINER | EXECUTIVE VICE PRESIDENT | 55 | $438,499 | $0 | $54,177 | $492,676 | 1 |
| LUIS MONTANER | PROFESSOR VICE PRESIDENT, SCIENTIFIC OPERATIONS | 55 | $349,845 | $0 | $61,220 | $411,065 | 1 |
| JENNIFER EVANS STACEY | VICE PRESIDENT, GEN COUNSEL, SEC & GOV RELATIONS | 55 | $304,784 | $0 | $45,132 | $349,916 | 1 |
| HEATHER A STEINMAN | VP FOR BUSINESS DEVELOP & E.D. TECH | 55 | $293,576 | $0 | $46,923 | $340,499 | 1 |
| MEENHARD HERLYN | PROFESSOR | 55 | $280,533 | $0 | $58,847 | $339,380 | 1 |
| JOSEPH TRAINOR | CHIEF FINANCIAL OFFICER | 55 | $265,681 | $0 | $52,381 | $318,062 | 3 |
| DAVID SPEICHER | PROFESSOR | 55 | $255,294 | $0 | $55,491 | $310,785 | 1 |
| RUGANG ZHANG | PROFESSOR | 55 | $261,685 | $0 | $44,715 | $306,400 | 1 |
| ANITA PEPPER | VICE PRESIDENT, INSTITUTIONAL ADVANCEMENT | 55 | $264,851 | $0 | $35,748 | $300,599 | 1 |
| HILDEGUND ERTL | PROFESSOR | 55 | $251,424 | $0 | $36,855 | $288,279 | 1 |
| JOANN MENDEL | VICE PRESIDENT, HUMAN RESOURCES | 55 | $204,007 | $0 | $33,638 | $237,645 | 1 |
| STEVEN V ABRAMNSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ELIZABETH MCKEE ANDERSON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| DOUGLAS S BRIGGS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| IRA BRIND | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 13 |
| RONALD CAPLAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| SCOTT COOPER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| ARTHUR DANTCHIK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| SUSAN B DILLON PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BRIAN H DOVEY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| DANIEL K FITZPATRICK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 18 |
| JOHN FRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 22 |
| JOSEPH A GOLDBLUM | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| RICHARD M HOROWITZ | TRUSTEE - BOARD VICE CHAIR | 4 | $0 | $0 | $0 | $0 | 1 |
| PERRY A LERNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JAMES W LOVETT | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 4 |
| SUSAN S MCDONALD PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ABRAHAM L MORRIS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR M PAPPAS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| RICHARD G PHILLIPS JR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WENDELL PRITCHETT PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| HELEN P PUDLIN ESQ | TRUSTEE - BOARD CHAIR | 4 | $0 | $0 | $0 | $0 | 1 |
| SAMUEL V RHOADS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| ROBERT H ROCK | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| GERALD B RORER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ADELE K SCHAEFFER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| MILTON S SCHNEIDER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| WILLIAM A SLAUGHTER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DANIEL H WHEELER | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| EDWARD ZIFF PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
2020 · 46 people listed · 12 paid, $4.8M · 362 employees · 45 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Dario Altieri MD | President & CEO, Director of Wistar Cancer Center | 55 | $666,522 | $0 | $40,977 | $707,499 | 1 |
| Luis Montaner | Professor Vice President, Scientific Operations | 55 | $486,113 | $0 | $60,679 | $546,792 | 1 |
| David B Weiner | Executive Vice President | 55 | $475,521 | $0 | $37,461 | $512,982 | 1 |
| Jennifer Evans Stacey | Vice President, Gen Counsel, Sec & Gov Relations | 55 | $406,571 | $0 | $46,684 | $453,255 | 1 |
| Heather A Steinman | VP for Business Develop & E. D. Tech | 55 | $338,630 | $0 | $41,032 | $379,662 | 1 |
| Meenhard Herlyn | Professor | 55 | $293,000 | $0 | $57,715 | $350,715 | 1 |
| Joseph Trainor | Chief Financial Officer | 55 | $285,221 | $0 | $45,604 | $330,825 | 3 |
| Rugang Zhang | Professor | 55 | $296,168 | $0 | $34,604 | $330,772 | 1 |
| David Speicher | Professor | 55 | $252,033 | $0 | $54,627 | $306,660 | 1 |
| Anita Pepper | Vice President, Institutional Advancement | 55 | $266,938 | $0 | $34,536 | $301,474 | 1 |
| Hildegund Ertl | Professor | 55 | $248,655 | $0 | $40,117 | $288,772 | 1 |
| JoAnn Mendel | Vice President, Human Resources | 55 | $216,883 | $0 | $35,872 | $252,755 | 1 |
| Steven V Abramson | Trustee (appointed 6/2020) | 1 | $0 | $0 | $0 | $0 | 1 |
| Elizabeth McKee Anderson | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Douglas S Briggs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Ira Brind | Trustee | 1 | $0 | $0 | $0 | $0 | 13 |
| Ronald Caplan | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| Morton Collins PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Scott Cooper | Trustee (appointed 9/2020) | 1 | $0 | $0 | $0 | $0 | 4 |
| Arthur Dantchik | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Susan B Dillon PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Brian H Dovey | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Daniel K Fitzpatrick | Trustee | 0 | $0 | $0 | $0 | $0 | 18 |
| Robert Fox | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| John Fry | Trustee | 1 | $0 | $0 | $0 | $0 | 22 |
| Joseph A Goldblum | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Richard M Horowitz | Trustee - Board Vice Chair | 4 | $0 | $0 | $0 | $0 | 1 |
| Herbert Kean MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Perry A Lerner | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| James W Lovett | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Susan S McDonald PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Maida Milone | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Abraham L Morris | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Arthur M Pappas | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Richard G Phillips Jr | Trustee (appointed 6/2020) | 1 | $0 | $0 | $0 | $0 | 1 |
| Wendell Pritchett PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Helen P Pudlin Esq | Trustee - Board Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Samuel V Rhoads | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert H Rock | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Gerald B Rorer | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Adele K Schaeffer | Trustee | 1 | $0 | $0 | $0 | $0 | 5 |
| Milton S Schneider | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| William A Slaughter | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Judith E Soltz | Trustee (until 9/2020) | 1 | $0 | $0 | $0 | $0 | 2 |
| Daniel H Wheeler | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Edward Ziff PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
2019 · 44 people listed · 12 paid, $4.5M · 391 employees · 55 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Dario Altieri MD | President & CEO, Director of Wistar Cancer Center | 55 | $628,055 | $0 | $40,108 | $668,163 | 1 |
| Luis Montaner | Professor Vice President, Scientific Operations | 55 | $447,902 | $0 | $59,720 | $507,622 | 1 |
| David B Weiner | Executive Vice President | 55 | $396,167 | $0 | $36,184 | $432,351 | 1 |
| Dmitry Gabrilovich | Professor | 55 | $342,327 | $0 | $48,212 | $390,539 | 1 |
| Jennifer Evans Stacey | Vice President, Gen Counsel, Sec & Gov Relations | 55 | $331,461 | $0 | $44,600 | $376,061 | 1 |
| Heather A Steinman | VP for Business Develop & E. D. Tech | 55 | $326,843 | $0 | $39,611 | $366,454 | 1 |
| Rugang Zhang | Professor | 55 | $287,846 | $0 | $50,012 | $337,858 | 1 |
| Frank Rauscher | Professor | 55 | $266,251 | $0 | $53,990 | $320,241 | 1 |
| Meenhard Herlyn | Professor | 55 | $258,203 | $0 | $54,635 | $312,838 | 1 |
| Joseph Trainor | Chief Financial Officer | 55 | $255,201 | $0 | $47,868 | $303,069 | 3 |
| Anita Pepper | Vice President, Institutional Advancement | 55 | $229,234 | $0 | $29,191 | $258,425 | 1 |
| JoAnn Mendel | Vice President, Human Resources | 55 | $201,562 | $0 | $31,245 | $232,807 | 1 |
| Elizabeth McKee Anderson | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Douglas S Briggs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Ira Brind | Trustee | 1 | $0 | $0 | $0 | $0 | 13 |
| Ronald Caplan | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| Morton Collins PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Arthur Dantchik | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Susan B Dillon PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Brian H Dovey | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Daniel K Fitzpatrick | Trustee | 0 | $0 | $0 | $0 | $0 | 18 |
| Robert Fox | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| John Fry | Trustee | 1 | $0 | $0 | $0 | $0 | 22 |
| Joseph A Goldblum | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Richard M Horowitz | Trustee - Board Vice Chair | 4 | $0 | $0 | $0 | $0 | 1 |
| Herbert Kean MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Perry A Lerner | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| James W Lovett | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Susan S McDonald PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Maida Milone | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Abraham L Morris | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Arthur M Pappas | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Wendell Pritchett PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Helen P Pudlin Esq | Trustee - Board Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Cavan Redmond | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Samuel V Rhoads | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert H Rock | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Gerald B Rorer | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Adele K Schaeffer | Trustee | 1 | $0 | $0 | $0 | $0 | 5 |
| Milton S Schneider | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| William A Slaughter | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Judith E Soltz | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Daniel H Wheeler | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Edward Ziff PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
2018 · 44 people listed · 12 paid, $4.3M · 378 employees · 74 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Dario Altieri MD | President & CEO, Director of Wistar Cancer Center | 55 | $547,321 | $0 | $39,283 | $586,604 | 1 |
| Luis Montaner | Professor Vice President, Scientific Operations | 55 | $371,663 | $0 | $57,744 | $429,407 | 1 |
| David B Weiner | Executive Vice President | 55 | $385,310 | $0 | $35,996 | $421,306 | 1 |
| Dmitry Gabrilovich | Professor | 55 | $357,055 | $0 | $46,846 | $403,901 | 1 |
| Jennifer Evans Stacey | Vice President, Gen Counsel, Sec & Gov Relations | 55 | $306,294 | $0 | $44,600 | $350,894 | 1 |
| Frank Rauscher | Professor | 55 | $296,248 | $0 | $52,965 | $349,213 | 1 |
| Heather A Steinman | VP for Business Develop & E. D. Tech | 55 | $306,010 | $0 | $37,505 | $343,515 | 1 |
| Meenhard Herlyn | Professor | 55 | $259,411 | $0 | $53,089 | $312,500 | 1 |
| David W Speicher | Professor | 55 | $252,320 | $0 | $49,918 | $302,238 | 1 |
| Joseph Trainor | Chief Financial Officer | 55 | $248,743 | $0 | $45,871 | $294,614 | 3 |
| Anita Pepper | Vice President, Institutional Advancement | 55 | $213,969 | $0 | $26,388 | $240,357 | 1 |
| JoAnn Mendel | Vice President, Human Resources | 55 | $186,459 | $0 | $29,635 | $216,094 | 1 |
| Elizabeth McKee Anderson | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Douglas S Briggs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Ira Brind | Trustee | 1 | $0 | $0 | $0 | $0 | 13 |
| Ronald Caplan | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| Morton Collins PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Susan B Dillon PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Brian H Dovey | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Daniel K Fitzpatrick | Trustee | 0 | $0 | $0 | $0 | $0 | 18 |
| Robert Fox | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| John Fry | Trustee | 1 | $0 | $0 | $0 | $0 | 22 |
| L Patrick Gage PhD | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Joseph A Goldblum | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Richard M Horowitz | Trustee - Board Vice Chair | 4 | $0 | $0 | $0 | $0 | 1 |
| Herbert Kean MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Perry A Lerner | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| James W Lovett | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Susan S McDonald PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Maida Milone | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Abraham L Morris | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Arthur M Pappas | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Wendell Pritchett PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Helen P Pudlin Esq | Trustee - Board Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Cavan Redmond | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Samuel V Rhoads | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert H Rock | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Gerald B Rorer | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Adele K Schaeffer | Trustee | 1 | $0 | $0 | $0 | $0 | 5 |
| Milton S Schneider | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| William A Slaughter | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Judith E Soltz | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Daniel H Wheeler | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Edward Ziff PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
2017 · 48 people listed · 11 paid, $3.5M · 387 employees · 66 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Dario Altieri MD | President & CEO, Director of Wistar Cancer Center | 55 | $546,174 | $0 | $35,100 | $581,274 | 1 |
| David B Weiner | Executive Vice President | 55 | $316,444 | $0 | $34,700 | $351,144 | 1 |
| Luis Montaner | Professor Vice President, Scientific Operations | 55 | $279,035 | $0 | $50,211 | $329,246 | 1 |
| Dmitry Gabrilovich | Professor | 55 | $258,743 | $0 | $57,475 | $316,218 | 1 |
| Jennifer Evans Stacey Esq | Vice President, General Counsel, Secretary & Gov | 55 | $252,793 | $0 | $51,730 | $304,523 | 1 |
| Frank Rauscher | Professor | 55 | $261,827 | $0 | $33,804 | $295,631 | 1 |
| Meenhard Herlyn | Professor | 55 | $236,548 | $0 | $53,656 | $290,204 | 1 |
| David W Speicher | Professor | 55 | $233,282 | $0 | $50,044 | $283,326 | 1 |
| Heather A Steinman PhD | VP for Business Develop & E. D. Tech | 55 | $231,552 | $0 | $35,343 | $266,895 | 1 |
| Joseph Trainor CPA | Chief Financial Officer | 55 | $201,059 | $0 | $48,090 | $249,149 | 3 |
| Anita Pepper PhD | Vice President, Institutional Advancement | 55 | $183,275 | $0 | $24,487 | $207,762 | 1 |
| Elizabeth McKee Anderson | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Douglas S Briggs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Ira Brind | Trustee | 1 | $0 | $0 | $0 | $0 | 13 |
| Ronald Caplan | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| Morton Collins PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Susan B Dillon PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Brian H Dovey | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Daniel K Fitzpatrick CFA | Trustee | 0 | $0 | $0 | $0 | $0 | 18 |
| Robert Fox | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| John Fry | Trustee (Beginning June 2017) | 1 | $0 | $0 | $0 | $0 | 22 |
| L Patrick Gage PhD | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| George W Gephart | Trustee (until June 2017) | 1 | $0 | $0 | $0 | $0 | 1 |
| Joseph A Goldblum | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Richard M Horowitz | Trustee - Board Vice Chair | 4 | $0 | $0 | $0 | $0 | 1 |
| Herbert Kean MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Perry A Lerner | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| James W Lovett | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Susan S McDonald PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Maida Milone | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Abraham L Morris | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Albert Ominsky Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Arthur M Pappas | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Vincent Price | Trustee (until July 2017) | 1 | $0 | $0 | $0 | $0 | 3 |
| Wendell Pritchett PhD | Trustee (Beginning Sept 2017) | 1 | $0 | $0 | $0 | $0 | 4 |
| Helen P Pudlin Esq | Trustee - Board Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Cavan Redmond | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Samuel V Rhoads | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert H Rock | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Gerald B Rorer | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Adele K Schaeffer | Trustee | 1 | $0 | $0 | $0 | $0 | 5 |
| Paul J Schmitt | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Milton S Schneider | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| William A Slaughter Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Judith E Soltz Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| David V Wachs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Daniel H Wheeler | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Edward Ziff PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
2015 · 46 people listed · 12 paid, $3.8M · 382 employees · 51 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Russel Kaufman MD | President and CEO until March, 2015 | 55 | $691,160 | $0 | $48,535 | $739,695 | 1 |
| Dario Altieri MD | President & CEO | 55 | $396,370 | $0 | $36,989 | $433,359 | 1 |
| Elizabeth OBrien Esquire | VP for Legal and External Affairs | 55 | $272,668 | $0 | $55,159 | $327,827 | 1 |
| Alan Stiles | Chief Operating Officer | 55 | $271,291 | $0 | $55,100 | $326,391 | 1 |
| Dmitry I Gabrilovich MD PhD | Professor | 55 | $265,695 | $0 | $25,978 | $291,673 | 1 |
| Meenhard Herlyn DVM DSc | Professor | 55 | $234,832 | $0 | $55,395 | $290,227 | 1 |
| Frank Rauscher PhD | Professor | 55 | $255,328 | $0 | $32,245 | $287,573 | 1 |
| Joseph Trainor CPA | Chief Financial Officer | 55 | $226,859 | $0 | $52,732 | $279,591 | 3 |
| David W Speicher PhD | Professor | 55 | $229,545 | $0 | $46,068 | $275,613 | 1 |
| Hildegund C J Ertl MD | Professor | 55 | $229,920 | $0 | $41,370 | $271,290 | 1 |
| Heather A Steinman PhD | VP for Business Develop & E. D. Tech | 55 | $178,847 | $0 | $30,011 | $208,858 | 1 |
| Anita Pepper PhD | Vice President, Institutional Advancement | 55 | $15,968 | $0 | $2,065 | $18,033 | 1 |
| Elizabeth McKee Anderson | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Van Billet | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Robert S Blank | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Douglas S Briggs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Ira Brind | Trustee | 1 | $0 | $0 | $0 | $0 | 13 |
| Ronald Caplan | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| Brian H Dovey | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Daniel K Fitzpatrick | Trustee | 0 | $0 | $0 | $0 | $0 | 18 |
| Robert A Fox | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| George W Gephart | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| L Patrick Gage | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Joseph A Goldblum | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Richard M Horowitz | Trustee | 4 | $0 | $0 | $0 | $0 | 1 |
| Herbert Kean | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Perry Lerner | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Maida Milone | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Susan S McDonald | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Abraham L Morris | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Albert Ominsky | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Arthur M Pappas | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Vincent Price | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
| Helen P Pudlin | Trustee | 5 | $0 | $0 | $0 | $0 | 1 |
| Samuel V Rhoads | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert H Rock | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Gerald B Rorer | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Adele K Schaeffer | Trustee | 1 | $0 | $0 | $0 | $0 | 5 |
| Paul J Schmitt | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Milton S Schneider | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| William A Slaughter Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Judith S Soltz | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| David V Wachs | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Daniel H Wheeler Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Edward Ziff PhD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Mark L Greenberg | PhD (Term expired in February 2015) | 1 | $0 | $0 | $0 | $0 | 2 |
2014 · 46 people listed · 13 paid, $4.0M · 359 employees · 50 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Russel Kaufman MD | President and CEO | 65 | $693,000 | $0 | $55,000 | $748,000 | 1 |
| Dario Altieri MD | Vice President and Cancer Center Director | 55 | $385,000 | $0 | $37,000 | $422,000 | 1 |
| Dmitry I Gabrilovich PhD | Professor | 55 | $258,000 | $0 | $62,000 | $320,000 | 1 |
| Alan Stiles | Chief Operating Officer and Treasurer | 55 | $255,000 | $0 | $57,000 | $312,000 | 1 |
| Eden A Graber | Vice President for Development and Marketing | 55 | $244,000 | $0 | $53,000 | $297,000 | 1 |
| Elizabeth O'Brien | Vice President | 55 | $240,000 | $0 | $56,000 | $296,000 | 1 |
| Meenhard Herlyn DVM DsC | Professor | 55 | $238,000 | $0 | $55,000 | $293,000 | 1 |
| Joseph G Trainor | Chief Financial Officer | 55 | $231,000 | $0 | $53,000 | $284,000 | 3 |
| Frank Rauscher PhD | Professor | 55 | $236,000 | $0 | $29,000 | $265,000 | 1 |
| David Speicher PhD | Professor | 55 | $231,000 | $0 | $33,000 | $264,000 | 1 |
| Hildegund Ertl MD | Professor | 55 | $226,000 | $0 | $35,000 | $261,000 | 1 |
| James Verzella | Construction Project Executive | 40 | $163,000 | $0 | $28,000 | $191,000 | 1 |
| George Hobbs | Vice President | 40 | $56,000 | $0 | $15,000 | $71,000 | 1 |
| Helen P Pudlin | Chair | 4 | $0 | $0 | $0 | $0 | 1 |
| Richard Horowitz | Vice Chair | 4 | $0 | $0 | $0 | $0 | 1 |
| Maida Milone | Secretary | 2 | $0 | $0 | $0 | $0 | 1 |
| Elizabeth McKee Anderson | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Van Billet | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Robert S Blank | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Douglas D Briggs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Ira Brind | Trustee | 1 | $0 | $0 | $0 | $0 | 13 |
| Ronald Caplan | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| Brian H Dovey | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Daniel Fitzpatrick | Trustee | 0 | $0 | $0 | $0 | $0 | 18 |
| Robert A Fox | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| L Patrick Gage PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Joseph A Goldblum | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Mark L Greenberg PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Herbert Kean MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Perry A Lerner | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Susan S McDonald | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Abraham L Morris | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Albert Ominsky Esq | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Arthur M Pappas | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Vincent Price PhD | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
| Samuel V Rhoads | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert H Rock | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Gerald B Rorer | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Adele K Schaeffer | Trustee | 1 | $0 | $0 | $0 | $0 | 5 |
| Paul J Schmitt | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Milton S Schneider | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| William A Slaughter Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Judith Soltz Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| David V Wachs | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Daniel H Wheeler Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Edward Ziff PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
2013 · 45 people listed · 12 paid, $3.5M · 376 employees · 49 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Russel Kaufman MD | President and CEO | 65 | $678,000 | $0 | $52,000 | $730,000 | 1 |
| Dario Altieri | Vice President and Cancer Center Director | 55 | $416,000 | $0 | $47,000 | $463,000 | 1 |
| Alan Stiles | Chief Operating Officer and Treasurer | 55 | $257,000 | $0 | $56,000 | $313,000 | 1 |
| Meenhard Herlyn DVM | Professor | 55 | $229,000 | $0 | $53,000 | $282,000 | 1 |
| Paul Lieberman PhD | Professor | 55 | $234,000 | $0 | $41,000 | $275,000 | 1 |
| Elizabeth O'Brien | Vice President | 55 | $209,000 | $0 | $57,000 | $266,000 | 1 |
| David Speicher PhD | Professor | 55 | $226,000 | $0 | $33,000 | $259,000 | 1 |
| Hildegund Ertl MD | Professor | 55 | $222,000 | $0 | $35,000 | $257,000 | 1 |
| Frank Rauscher PhD | Professor | 55 | $217,000 | $0 | $30,000 | $247,000 | 1 |
| George Hobbs | Vice President | 40 | $134,000 | $0 | $44,000 | $178,000 | 1 |
| Larry Keinath | Vice President | 33 | $144,000 | $0 | $30,000 | $174,000 | 1 |
| Joseph G Trainor | Chief Financial Officer | 55 | $84,000 | $0 | $11,000 | $95,000 | 3 |
| Helen P Pudlin | Chair | 4 | $0 | $0 | $0 | $0 | 1 |
| Richard Horowitz | Vice Chair | 4 | $0 | $0 | $0 | $0 | 1 |
| Maida Milone | Secretary | 2 | $0 | $0 | $0 | $0 | 1 |
| Elizabeth McKee Anderson | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Van Billet | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert S Blank | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Douglas D Briggs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Ira Brind | Trustee | 1 | $0 | $0 | $0 | $0 | 13 |
| Ronald Caplan | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| Brian H Dovey | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Daniel Fitzpatrick | Trustee | 1 | $0 | $0 | $0 | $0 | 18 |
| Robert A Fox | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| L Patrick Gage PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Joseph A Goldblum | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Mark L Greenberg PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Herbert Kean MD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Faye Olivieri-Kozich | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Susan S McDonald | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Abraham L Morris | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Albert Ominsky Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Arthur M Pappas | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Vincent Price PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Samuel V Rhoads | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert H Rock | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Gerald B Rorer | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Adele K Schaeffer | Trustee | 1 | $0 | $0 | $0 | $0 | 5 |
| Paul J Schmitt | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Milton S Schneider | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| William A Slaughter Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Judith Soltz Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| David V Wachs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Daniel H Wheeler Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Edward Ziff PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
2012 · 44 people listed · 11 paid, $3.5M · 362 employees · 11 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Russel Kaufman MD | President and CEO | 65 | $681,000 | $0 | $43,000 | $724,000 | 1 |
| Dario Altieri | Vice President and Cancer Center Director | 55 | $413,000 | $0 | $46,000 | $459,000 | 1 |
| Elizabeth O'Brien | Vice President | 55 | $266,000 | $0 | $58,000 | $324,000 | 1 |
| Larry Keinath | Vice President | 55 | $268,000 | $0 | $43,000 | $311,000 | 1 |
| Meenhard Herlyn DVM | Professor | 55 | $241,000 | $0 | $54,000 | $295,000 | 1 |
| David Speicher PhD | Professor | 55 | $238,000 | $0 | $34,000 | $272,000 | 1 |
| Hildegund Ertl MD | Professor | 55 | $229,000 | $0 | $40,000 | $269,000 | 1 |
| Ellen Pure PhD | Professor | 55 | $213,000 | $0 | $40,000 | $253,000 | 1 |
| Peter Corrado | Vice President | 55 | $203,000 | $0 | $47,000 | $250,000 | 1 |
| Frank Rauscher PhD | Professor | 55 | $214,000 | $0 | $32,000 | $246,000 | 1 |
| Alan Stiles | Chief Operating Officer and Treasurer | 55 | $110,000 | $0 | $17,000 | $127,000 | 1 |
| Helen P Pudlin | Chair | 3 | $0 | $0 | $0 | $0 | 1 |
| Richard Horowitz | Vice Chair | 3 | $0 | $0 | $0 | $0 | 1 |
| Maida Milone | Secretary | 2 | $0 | $0 | $0 | $0 | 1 |
| Seymour S Preston III | Treasurer | 1 | $0 | $0 | $0 | $0 | 2 |
| Elizabeth McKee Anderson | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert S Blank | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Van Billet | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Douglas D Briggs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Ira Brind | Trustee | 1 | $0 | $0 | $0 | $0 | 13 |
| Ronald Caplan | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| Brian H Dovey | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Daniel Fitzpatrick | Trustee | 1 | $0 | $0 | $0 | $0 | 18 |
| Robert A Fox | Trustee | 2 | $0 | $0 | $0 | $0 | 3 |
| Joseph A Goldblum | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Herbert Kean MD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Faye Olivieri-Kozich | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Susan S McDonald | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Abraham L Morris | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| I Wistar Morris | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Albert Ominsky Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Arthur M Pappas | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Vincent Price PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Samuel V Rhoads | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert H Rock | Trustee | 1 | $0 | $0 | $0 | $0 | 4 |
| Gerald B Rorer | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Adele K Schaeffer | Trustee | 1 | $0 | $0 | $0 | $0 | 5 |
| Paul J Schmitt | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Milton S Schneider | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Judith Soltz Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 2 |
| Lawrence V Stein | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| David V Wachs | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Daniel H Wheeler Esq | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Edward Ziff PhD | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
2011 · 44 people listed · 10 paid, $3.3M · 467 employees · 12 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Russel Kaufman MD | President and CEO | 65 | $685,000 | $0 | $48,000 | $733,000 | 1 |
| Dario Altieri | Vice President and Cancer Center Director | 55 | $341,000 | $0 | $51,000 | $392,000 | 1 |
| Elizabeth O'Brien | Vice President | 40 | $243,000 | $0 | $62,000 | $305,000 | 1 |
| Larry Keinath | Vice President | 55 | $251,000 | $0 | $48,000 | $299,000 | 1 |
| Meenhard Herlyn DVM | Professor | 55 | $217,000 | $0 | $60,000 | $277,000 | 1 |
| Hildegund Ertl MD | Professor | 55 | $222,000 | $0 | $45,000 | $267,000 | 1 |
| David Speicher PhD | Professor | 55 | $226,000 | $0 | $39,000 | $265,000 | 1 |
| Ellen Pure PhD | AVP Academic Affairs and Professor | 55 | $202,000 | $0 | $45,000 | $247,000 | 1 |
| Peter Corrado | Vice President | 55 | $188,000 | $0 | $51,000 | $239,000 | 1 |
| Frank Rauscher PhD | Professor | 55 | $204,000 | $0 | $34,000 | $238,000 | 1 |
| Brian H Dovey | Chair | 0 | $0 | $0 | $0 | $0 | 1 |
| Richard Horowitz | Vice Chair | 0 | $0 | $0 | $0 | $0 | 1 |
| Helen P Pudlin | Vice Chair | 0 | $0 | $0 | $0 | $0 | 1 |
| Maida Milone | Secretary | 0 | $0 | $0 | $0 | $0 | 1 |
| Seymour S Preston III | Treasurer | 0 | $0 | $0 | $0 | $0 | 2 |
| Elizabeth McKee Anderson | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Robert S Blank | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Dani Bolognesi PhD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Douglas D Briggs | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Ira Brind | Trustee | 0 | $0 | $0 | $0 | $0 | 13 |
| Ronald Caplan | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
| Daniel Fitzpatrick | Trustee | 0 | $0 | $0 | $0 | $0 | 18 |
| Robert A Fox | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
| Herbert Kean MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Hilary Koprowski MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Faye Olivieri-Kozich | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Dan W Matthias | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Susan S McDonald | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| I Wistar Morris | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Albert Ominsky Esq | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Vincent Price PhD | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
| Samuel V Rhoads | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Robert H Rock | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Gerald B Rorer | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Adele K Schaeffer | Trustee | 0 | $0 | $0 | $0 | $0 | 5 |
| Paul J Schmitt | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Milton S Schneider | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Judith Soltz Esq | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Lawrence V Stein | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Arthur L Stokes MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Kevin M Tucker | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| David V Wachs | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Daniel H Wheeler Esq | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Edward Ziff PhD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
2010 · 44 people listed · 10 paid, $2.9M · 467 employees · 25 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Russel Kaufman MD | President and CEO | 65 | $584,000 | $0 | $39,000 | $623,000 | 1 |
| Elizabeth O'Brien | Vice President | 40 | $240,000 | $0 | $54,000 | $294,000 | 1 |
| Larry Keinath | Vice President | 55 | $238,000 | $0 | $45,000 | $283,000 | 1 |
| Meenhard Herlyn DVM | Professor | 55 | $226,000 | $0 | $47,000 | $273,000 | 1 |
| David Speicher PhD | Professor | 55 | $223,000 | $0 | $38,000 | $261,000 | 1 |
| Hildegund Ertl MD | Professor | 55 | $216,000 | $0 | $43,000 | $259,000 | 1 |
| Ramin Shiekhattar PhD | Professor | 55 | $200,000 | $0 | $49,000 | $249,000 | 1 |
| Ellen Pure PhD | AVP Academic Affairs | 55 | $203,000 | $0 | $42,000 | $245,000 | 1 |
| Peter Corrado | Vice President | 55 | $192,000 | $0 | $48,000 | $240,000 | 1 |
| Dario Altieri | Vice President | 55 | $162,000 | $0 | $20,000 | $182,000 | 1 |
| Brian H Dovey | Chair | 0 | $0 | $0 | $0 | $0 | 1 |
| Richard Horowitz | Vice Chair | 0 | $0 | $0 | $0 | $0 | 1 |
| Helen P Pudlin | Vice Chair | 0 | $0 | $0 | $0 | $0 | 1 |
| Doris Taxin | Secretary | 0 | $0 | $0 | $0 | $0 | 1 |
| Seymour S Preston III | Treasurer | 0 | $0 | $0 | $0 | $0 | 2 |
| Robert S Blank | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Dani Bolognesi PhD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Douglas D Briggs | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Ira Brind | Trustee | 0 | $0 | $0 | $0 | $0 | 13 |
| Ronald Caplan | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
| Richard E Fitzpatrick | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Robert A Fox | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
| Gail Hearn | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Herbert Kean MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Hilary Koprowski MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Faye Olivieri-Kozich | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Dan W Matthias | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Susan S McDonald PhD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Maida Milone Esq | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Albert Ominsky Esq | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Vincent Price PhD | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
| Samuel V Rhoads | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Robert H Rock | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Gerald B Rorer | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Adele K Schaeffer | Trustee | 0 | $0 | $0 | $0 | $0 | 5 |
| Paul J Schmitt | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Milton S Schneider | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Judith Soltz Esq | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Arthur L Stokes MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Kevin M Tucker | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| George J Vergis PhD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| David V Wachs | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Daniel H Wheeler Esq | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Edward Ziff PhD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2025 · 5 contractors · $8.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| IMC CONSTRUCTION | MALVERN, PA | CONSTRUCTION SERVICES | $4,134,000 |
| P AGNES INC | PHILADELPHIA, PA | CONSTRUCTION SERVICES | $2,372,000 |
| HURON CONSULTING SERVICES LLC | CHICAGO, IL | CONSULTING SERVICES | $837,000 |
| ALLIED UNIVERSAL SECURITY SERVICES | PHILADELPHIA, PA | SECURITY SERVICES | $742,000 |
| ENHANCITY INC | HILLSBOROUGH, NJ | JANITORIAL SERVICES | $691,000 |
2024 · 5 contractors · $4.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| IMC CONSTRUCTION | MALVERN, PA | CONSTRUCTION SERVICES | $1,994,000 |
| ALLIED UNIVERSAL SECURITY SERVICES | PHILADELPHIA, PA | SECURITY SERVICES | $818,000 |
| DAVOS PHARMA | UPPER SADDLE RIVER, NJ | PHARMACEUTICAL SERVICES | $495,000 |
| RIVERSIDE LAW LLP | WAYNE, PA | LEGAL SERVICES | $463,000 |
| TRIUMVIRATE ENVIRONMENTAL INC | HARTFORD, CT | ENVIRONMENTAL SOLUTIONS SERVICES | $460,000 |
2023 · 5 contractors · $3.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE ARTHUR JACKSON COMPANY | UPPER DARBY, PA | JANITORIAL SERVICES | $907,000 |
| ALLIED UNIVERSAL SECURITY SERVICES | PHILADELPHIA, PA | SECURITY SERVICES | $708,000 |
| ASCENDIA PHARMACEUTICALS INC | NORTH BRUNSWICK, NJ | DEVELOPMENT SERVICES | $596,000 |
| RIVERSIDE LAW LLP | WAYNE, PA | LEGAL SERVICES | $528,000 |
| TRIUMVIRATE ENVIRONMENTAL INC | HARTFORD, CT | ENVIRONMENTAL SOLUTIONS SERVICES | $463,000 |
2022 · 5 contractors · $2.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE ARTHUR JACKSON COMPANY | UPPER DARBY, PA | JANITORIAL SERVICES | $743,000 |
| ALLIED UNIVERSAL SECURITY SERVICES | PHILADELPHIA, PA | SECURITY SERVICES | $506,000 |
| TRIUMVIRATE ENVIRONMENTAL INC | HARTFORD, CT | WASTE MANAGEMENT | $386,000 |
| CHRISTIANA CARE HEALTH SERVICES INC | NEWARK, DE | HEALTHCARE SERVICES | $291,000 |
| HERMAN GOLDNER CO INC | PHILADELPHIA, PA | MECHANICAL CONSTRUCTION | $285,000 |
2021 · 5 contractors · $2.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| THE ARTHUR JACKSON COMPANY | UPPER DARBY, PA | JANITORIAL SERVICES | $891,000 |
| ALLIED UNIVERSAL SECURITY SERVICES | PHILADELPHIA, PA | SECURITY SERVICES | $608,000 |
| MARA RESTORATION INC | ORELAND, PA | RESTORATION SERVICES | $422,000 |
| TRIUMVIRATE ENVIRONMENTAL INC | HARTFORD, CT | WASTE MANAGEMENT | $297,000 |
| JJ WHITE INC | PHILADELPHIA, PA | RESTORATION SERVICES | $289,000 |
2020 · 5 contractors · $2.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| The Arthur Jackson Company | Upper Darby, PA | Janitorial services | $795,000 |
| Allied Universal Security Services | Philadelphia, PA | Security services | $439,000 |
| AMRI Inc | Chicago, IL | Scientific expertise services | $429,000 |
| Willis Towers Watson Northeast Inc | New York, NY | Insurance broker | $229,000 |
| Triumvirate Environmental Inc | Hartford, CT | Waste management | $227,000 |
2019 · 5 contractors · $2.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| The Arthur Jackson Company | Upper Darby, PA | Janitorial services | $745,000 |
| W H Myers Construction Co | Philadelphia, PA | Construction | $571,000 |
| Mara Restoration Inc | Oreland, PA | Restoration and preservation | $416,000 |
| Allied Universal Security Services | Philadelphia, PA | Security services | $375,000 |
| Oliver Fire Protection & Security | King of Prussia, PA | Safety services | $374,000 |
2018 · 5 contractors · $1.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| The Arthur Jackson Company | Upper Darby, PA | Janitorial services | $620,000 |
| Allied Universal Security Services | Philadelphia, PA | Security services | $551,000 |
| Howson and Howson LLP | Blue Bell, PA | Legal services | $211,000 |
| Jacobswypers Architects LLP | Philadelphia, PA | Architecture | $136,000 |
| Colonial Consulting LLC | Baltimore, MD | Consulting services | $126,000 |
2017 · 5 contractors · $1.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| The Arthur Jackson Company | Philadelphia, PA | Janitorial services | $577,516 |
| Allied Universal Security Services | Philadelphia, PA | Security services | $451,917 |
| Wolf Scott Associates Inc | Norristown, PA | Architecturial services | $240,302 |
| W H Myers Construction Co | Philadelphia, PA | Construction services | $167,617 |
| Howson and Howson LLP | Blue Bell, PA | Legal services | $137,382 |
2015 · 5 contractors · $1.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| The Arthur Jackson Company | Philadelphia, PA | Janitorial Services | $563,471 |
| L F Driscoll Company | Bala Cynwyd, PA | Construction Management | $445,592 |
| Allied Barton Security Services | Conshohocken, PA | Security Services | $419,351 |
| Cambridge Computer Services Inc | Philadelphia, PA | Computer Services | $248,363 |
| Ballinger | Philadelphia, PA | Architect & Engineer | $237,823 |
2014 · 5 contractors · $21.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| L F Driscoll Co LLC | Bala Cynwyd, PA | Construction Management | $19,331,000 |
| Architectural Woodwork Industries | Philadelphia, PA | Construction Management | $667,000 |
| AlliedBarton Security Services | Conshohocken, PA | Security services | $427,000 |
| ABM Mid-Atlantic Inc | King of Prussia, PA | Janitorial | $404,000 |
| Flatiron Building Company | Philadelphia, PA | Construction Management | $305,000 |
2013 · 5 contractors · $51.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| L F Driscoll Co LLC | Construction Management | $49,963,000 | |
| AlliedBarton Security Services | Security services | $675,000 | |
| Ballinger | Architecture Engineering Planning Interior Design | $470,000 | |
| ABM Mid-Atlantic Inc | Janitorial | $446,000 | |
| Howson & Howson LLP | Legal services | $186,000 |
2012 · 5 contractors · $19.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| L F Driscoll Co LLC | Bala Cynwyd, PA | Construction Management | $17,041,000 |
| Ballinger | Philadelphia, PA | Architecture Engineering Planning Interior Design | $837,000 |
| Laredo Mechanical LLC | Plymouth Meeting, PA | HVAC Services | $658,000 |
| ABM Mid-Atlantic Inc | King of Prussia, PA | Janitorial | $422,000 |
| AlliedBarton Security Services | Conshohocken, PA | Security services | $333,000 |
2011 · 5 contractors · $7.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| L F Driscoll Co LLC | Bala Cynwyd, PA | Construction Management | $4,700,000 |
| Ballinger | Philadelphia, PA | Architecture Engineering Planning Interior Design | $1,824,000 |
| Laredo Mechanical LLC | Plymouth Meeting, PA | HVAC Services | $544,000 |
| ABM Mid-Atlantic Inc | King of Prussia, PA | Janitorial | $514,000 |
| Schnader Harrison Segal & Lewis LLP | Philadelphia, PA | Legal Services | $246,000 |
2010 · 5 contractors · $3.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Ballinger | Philadelphia, PA | Architecture Engineering Planning Interior Design | $1,844,000 |
| Schnader Harrison Segal & Lewis LLP | Philadelphia, PA | Legal services | $524,000 |
| ABM Mid-Atlantic Inc | King of Prussia, PA | Janitorial | $421,000 |
| Jones Lang LaSalle LLC | Chicago, IL | Project & Development Management | $210,000 |
| Philadelphia Consultant Security Group | Philadelphia, PA | Security services | $197,000 |
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2025 · Form 990 | ||||||||
| $77,322,000 | $89,910,000 | $419,150,000 | $349,753,000 | $57,680,000 | $260,000 | $4,224,000 | 377 | 73 |
| 2024 · Form 990 | ||||||||
| $93,130,000 | $93,862,000 | $424,946,000 | $341,597,000 | $74,373,000 | $2,535,000 | $4,229,000 | 455 | 68 |
| 2023 · Form 990 | ||||||||
| $181,250,000 | $91,822,000 | $402,392,000 | $322,110,000 | $70,736,000 | $4,069,000 | $2,884,000 | 457 | 62 |
| 2022 · Form 990 | ||||||||
| $90,721,000 | $85,062,000 | $381,486,000 | $298,116,000 | $72,907,000 | $4,982,000 | $2,536,000 | 435 | 46 |
| 2021 · Form 990 | ||||||||
| $115,831,000 | $69,091,000 | $414,460,000 | $334,502,000 | $95,470,000 | $4,522,000 | $2,724,000 | 386 | 46 |
| 2020 · Form 990 | ||||||||
| $67,263,000 | $68,907,000 | $343,834,000 | $266,552,000 | $51,614,000 | $3,021,000 | $2,938,000 | 362 | 45 |
| 2019 · Form 990 | ||||||||
| $64,459,000 | $68,702,000 | $320,484,000 | $250,164,000 | $48,234,000 | $4,197,000 | $2,637,000 | 391 | 55 |
| 2018 · Form 990 | ||||||||
| $81,845,000 | $69,520,000 | $303,805,000 | $232,365,000 | $51,780,000 | $4,020,000 | $2,453,000 | 378 | 74 |
| 2017 · Form 990 | ||||||||
| $86,105,000 | $72,233,000 | $306,940,000 | $237,111,000 | $59,722,000 | $1,097,000 | $2,143,000 | 387 | 66 |
| 2015 · Form 990 | ||||||||
| $92,237,000 | $59,156,000 | $267,442,000 | $193,707,000 | $45,984,000 | $3,295,000 | $2,334,000 | 382 | 51 |
| 2014 · Form 990 | ||||||||
| $68,958,000 | $57,908,000 | $241,477,000 | $160,725,000 | $39,654,000 | $3,108,000 | $2,621,000 | 359 | 50 |
| 2013 · Form 990 | ||||||||
| $65,963,000 | $57,593,000 | $246,413,000 | $160,015,000 | $39,506,000 | $2,320,000 | $2,220,000 | 376 | 49 |
| 2013 · Form 990 | ||||||||
| $65,963,000 | $57,593,000 | $246,413,000 | $160,015,000 | $39,506,000 | $2,320,000 | $2,220,000 | 376 | 49 |
| 2012 · Form 990 | ||||||||
| $67,424,000 | $62,072,000 | $193,555,000 | $142,814,000 | $47,565,000 | $1,693,000 | $2,196,000 | 362 | 11 |
| 2011 · Form 990 | ||||||||
| $92,311,000 | $60,061,000 | $159,446,000 | $132,042,000 | $68,019,000 | $1,526,000 | $1,969,000 | 467 | 12 |
| 2010 · Form 990 | ||||||||
| $67,073,000 | $56,338,000 | $121,142,000 | $110,901,000 | $12,908,000 | $38,537,000 | $1,622,000 | 467 | 25 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- THE UNIVERSITY OF THE ARTS Philadelphia, PA · 3 people in common (Daniel K Fitzpatrick, Ira Brind, Ronald Caplan)
- PHILADELPHIA ORCHESTRA ASSOCIATION Philadelphia, PA · 2 people in common (Adele K Schaeffer, Robert H Rock)
- YOUNG SCHOLARS CHARTER SCHOOL INC Philadelphia, PA · 2 people in common (Ira Brind, James Lovett)
- SCHOLAR ACADEMIES Malvern, PA · 2 people in common (Ira Brind, James Lovett)
- THE UNION LEAGUE OF PHILADELPHIA Radnor, PA · 1 person in common (Daniel K Fitzpatrick)
- PHILADELPHIA MUSEUM OF ART Philadelphia, PA · 1 person in common (Ira Brind)
- PHILADELPHIA WORKS INC Philadelphia, PA · 1 person in common (Daniel K Fitzpatrick)
- URBAN AFFAIRS COALITION Philadelphia, PA · 1 person in common (Daniel K Fitzpatrick)
- CURTIS INSTITUTE OF MUSIC Philadelphia, PA · 1 person in common (Robert H Rock)
- CONNELLY FOUNDATION W Cnshohocken, PA · 1 person in common (Ira Brind)
- ACADEMY OF NATURAL SCIENCES OF PHILADELPHIA Philadelphia, PA · 1 person in common (Gerald B Rorer)
- THE CHAMBER OF COMMERCE FOR GREATER PHILADELPHIA Philadelphia, PA · 1 person in common (Daniel K Fitzpatrick)
- OPERA PHILADELPHIA Philadelphia, PA · 1 person in common (Ira Brind)
- ENCORE SERIES INC Philadelphia, PA · 1 person in common (Daniel K Fitzpatrick)
- PHILADELPHIA ORCHESTRA AND KIMMEL CENTER INC Philadelphia, PA · 1 person in common (Adele K Schaeffer)
- MARY LOUISE CURTIS BOK FOUNDATION Philadelphia, PA · 1 person in common (Robert H Rock)
- NATIONAL LIBERTY MUSEUM Philadelphia, PA · 1 person in common (Ronald Caplan)
- ACADEMY OF MUSIC OF PHILADELPHIA INC Philadelphia, PA · 1 person in common (Adele K Schaeffer)
- FOREIGN POLICY RESEARCH INSTITUTE Philadelphia, PA · 1 person in common (Adele K Schaeffer)
- YPO INC Wilmington, DE · 1 person in common (Ira Brind)
Funders of this organization
81 grantors reported grants to this organization, $57,454,447 in all, tax years 2009 to 2025; the 25 largest shown (all 81). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Type | Match | Years given | Grants | Total | Latest year | Latest year's amount | Grants |
|---|---|---|---|---|---|---|---|---|
| GATES FOUNDATION | Private foundation | Fuzzy filed as “WISTAR INSTITUTE OF ANATOMY & BIOLOGY” | 2018-2024 | 13 | $9,257,930 | 2024 | $256,151 | show |
| VANGUARD CHARITABLE ENDOWMENT PROGRAM | DAF sponsor | Exact | 2021-2022, 2024 | 3 | $9,117,000 | 2024 | $9,031,000 | show |
| PEW CHARITABLE TRUSTS | DAF sponsor | Exact | 2010, 2013, 2016, 2019, 2022-2023 | 7 | $5,300,000 | 2023 | $75,000 | show |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | DAF sponsor | Exact | 2016, 2018-2024 | 8 | $2,312,300 | 2024 | $366,750 | show |
| JOHNS HOPKINS UNIVERSITY | DAF sponsor | Exact | 2018-2024 | 7 | $2,113,121 | 2024 | $218,903 | show |
| SUSAN G KOMEN BREAST CANCER FOUNDATION | Public charity | Exact | 2010-2014, 2017-2021, 2023 | 11 | $2,099,998 | 2023 | $60,000 | show |
| AMERICAN CANCER SOCIETY INC | Public charity | Exact | 2009, 2011, 2014, 2018-2019 | 5 | $2,034,000 | 2019 | $400,000 | show |
| THE V FOUNDATION | Public charity | Exact | 2011, 2018-2019, 2023 | 4 | $1,800,000 | 2023 | $1,200,000 | show |
| OVARIAN CANCER RESEARCH FUND INC | Public charity | Exact | 2015-2016, 2018-2020, 2025 | 6 | $1,375,000 | 2025 | $100,000 | show |
| DONOR ADVISED CHARITABLE GIVING | DAF sponsor | Exact | 2016-2024 | 9 | $1,338,650 | 2024 | $383,500 | show |
| GS DONOR ADVISED PHILANTHROPY FUND FOR WEALTH MANAGEMENT INC | DAF sponsor | Exact | 2018-2021, 2023-2024 | 6 | $1,283,042 | 2024 | $85,000 | show |
| MORGAN STANLEY GLOBAL IMPACT FUNDING TRUST INC | DAF sponsor | Exact | 2018, 2021-2022 | 3 | $1,163,040 | 2022 | $200,359 | show |
| TOBIN FAMILY FOUNDATION | Private foundation | Fuzzy filed as “THE WISTAR INSTITUTE OF ANATOMY & BIOLOGY” | 2016-2024 | 9 | $1,156,470 | 2024 | $25,000 | show |
| THOMAS JEFFERSON UNIVERSITY | Public charity | Exact | 2014-2015, 2019-2024 | 8 | $1,134,480 | 2024 | $156,316 | show |
| PHILADELPHIA FOUNDATION | DAF sponsor | Exact | 2010, 2012, 2014, 2016, 2018-2021, 2023-2024 | 10 | $1,006,600 | 2024 | $100,500 | show |
| ISAAC J WISTAR | Private foundation | Fuzzy filed as “WISTAR INSTITUTE OF ANATOMY & BIOLOGY” | 2011-2025 | 15 | $973,069 | 2025 | $74,098 | show |
| DREXEL UNIVERSITY | Public charity | Exact | 2017-2023 | 7 | $962,278 | 2023 | $78,099 | show |
| YALE UNIVERSITY | DAF sponsor | Exact | 2018-2024 | 7 | $852,182 | 2024 | $376,463 | show |
| PHILADELPHIA WORKS INC | Public charity | Exact | 2018, 2020-2024 | 6 | $819,348 | 2024 | $378,396 | show |
| THE FOUNDATION FOR AIDS RESEARCH | Public charity | Exact | 2018-2024 | 7 | $767,246 | 2024 | $189,931 | show |
| MELANOMA RESEARCH FOUNDATION | Public charity | Exact | 2012, 2015, 2019-2020, 2024 | 5 | $725,000 | 2024 | $250,000 | show |
| THE CHILDRENS HOSPITAL OF PHILADELPHIA | Public charity | Exact | 2011-2022 | 12 | $708,055 | 2022 | $53,302 | show |
| UNIVERSITY OF NOTRE DAME DU LAC | DAF sponsor | Exact | 2019-2021 | 3 | $590,598 | 2021 | $129,520 | show |
| GATEWAY FOR CANCER RESEARCH INC | Public charity | Exact | 2017, 2022 | 2 | $500,000 | 2022 | $250,000 | show |
| GEORGETOWN UNIVERSITY | Public charity | Exact | 2021-2024 | 4 | $496,564 | 2024 | $6,973 | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| AMERICAN ASSOCIATION FOR CANCER RESEARCH | PA | H30 | $129,520,731 | $97,689,916 | CHIEF EXECUTIVE OFFICER | $1,705,978 | Same NTEE code H30, revenue within 2x, same state, similar mission |
| INSTITUTE FOR CANCER RESEARCH | PA | H30 | $94,545,853 | $104,429,815 | Director | $2,136,271 | Same NTEE code H30, revenue within 2x, same state |
| NSABP FOUNDATION INC | PA | H30 | $44,121,085 | $37,560,448 | CHIEF FINANCIAL OFFICER (UNTIL 4/30/25) | $324,166 | Same NTEE code H30, revenue within 2x, same state |
| CENTRE COUNTY CANCER CENTER | PA | H30 | $43,304,913 | $45,920,267 | EXECUTIVE VP & CFO | $933,925 | Same NTEE code H30, revenue within 2x, same state |
| VAN ANDEL RESEARCH INSTITUTE | MI | H30 | $112,738,485 | $118,913,786 | CHIEF INVESTMENT OFFICER | $1,722,571 | Same NTEE code H30, revenue within 2x |
| THE GOG FOUNDATION INC | MD | H30 | $92,424,680 | $82,222,187 | CFO | $384,772 | Same NTEE code H30, revenue within 2x |
| NRG ONCOLOGY FOUNDATION INC | PA | H30 | $35,451,240 | $35,536,029 | TREASURER | $200,003 | Same NTEE code H30, revenue within 5x, same state |
| CANCER RESEARCH INSTITUTE INC | NY | H30 | $35,485,656 | $42,146,188 | FORMER CEO (THRU 8/2024) | $747,735 | Same NTEE code H30, revenue within 5x |
| BECKMAN RESEARCH INSTITUTE | CA | H30 | $332,532,052 | $385,146,731 | PRESIDENT & CEO | $7,115,860 | Same NTEE code H30, revenue within 5x |
| BARBARA ANN KARMANOS CANCER INSTITUTE | MI | H30 | $27,111,385 | $33,992,462 | BOARD MEMBER | $13,036,599 | Same NTEE code H30, revenue within 5x |
| ADDGENE INC | MA | H30 | $26,391,816 | $27,557,989 | EVP/COO (Ended 10/24) | $511,427 | Same NTEE code H30, revenue within 5x |
| LOUISIANA CANCER RESEARCH CENTER OF LSU HEALTH SCIENCES CENTER IN NO | LA | H30 | $25,078,516 | $23,520,798 | CAO | $255,091 | Same NTEE code H30, revenue within 5x |
| MARY CROWLEY MEDICAL RESEARCH CENTER | TX | H30 | $20,603,348 | $17,107,470 | EXECUTIVE MEDICAL DIRECTOR | $732,089 | Same NTEE code H30, revenue within 5x |
| DANA FARBER MASS GENERAL BRIGHAM CANCER CARE INC | MA | H30 | $171,278,142 | $170,718,385 | FORMER OFFICER | $2,679,650 | Same NTEE code H30, revenue within 5x |
| AMERICAN INSTITUTE FOR CANCER RESEARCH | VA | H30 | $11,011,192 | $11,992,534 | SENIOR VP DEVELOPMENT | $233,856 | Same NTEE code H30, revenue within 10x |
| CANCER RESEARCH AND BIOSTATISTICS | WA | H30 | $11,321,174 | $11,743,816 | PRESIDENT AND CEO | $464,367 | Same NTEE code H30, revenue within 10x |
| ADVANCED MEDICAL RESEARCH FOUNDATION INC | MA | H30 | $9,383,947 | $2,756,732 | TREASURER | $135,740 | Same NTEE code H30, revenue within 10x |
| INTERNATIONAL MYELOMA SOCIETY | H30 | $11,815,468 | $9,724,228 | Secretary | $0 | Same NTEE code H30, revenue within 10x | |
| COUNT ME IN INC | MA | H30 | $11,767,611 | $5,257,373 | Director/President (unt 12/22) | $181,768 | Same NTEE code H30, revenue within 10x |
| PREVENT CANCER FOUNDATION | VA | H30 | $10,018,961 | $8,719,694 | Chief Executive Officer | $362,187 | Same NTEE code H30, revenue within 10x |
| CANCER RESEARCH AMERICA NFCR INC | MD | H30 | $11,095,696 | $9,799,090 | PRESIDENT/CEO | $557,229 | Same NTEE code H30, revenue within 10x |
| ULTA BEAUTY CHARITABLE FOUNDATION | IL | H30 | $11,854,534 | $12,890,343 | President | $0 | Same NTEE code H30, revenue within 10x |
| CHORDOMA FOUNDATION | NC | H30 | $13,413,691 | $6,132,279 | HEAD OF PHILANTHROPY | $243,190 | Same NTEE code H30, revenue within 10x |
| TRANSLATIONAL RESEARCH IN ONCOLOGY US INC | CA | H30 | $9,656,261 | $9,555,292 | COO | $402,739 | Same NTEE code H30, revenue within 10x |
| THE LEONARD AND MADLYN ABRAMSON FAMILY CANCER RESEARCH INSTITUTE | PA | H30 | $2,360,577 | $1,014,720 | PRESIDENT/EXECUTIVE DIRECT | $1,186,473 | Same NTEE code H30, revenue differs more than 10x, same state |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2025 · Form 990 · $89,910,000 spent · pay $38,391,000 · grants $0 · events $6,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $25,768,000 | $19,730,000 | $5,472,000 | $566,000 | 28.7% | |
| Other (as described) | SUBAWARDS | $11,643,000 | $11,643,000 | - | - | 12.9% |
| Depreciation and depletion | $11,429,000 | $10,920,000 | $485,000 | $24,000 | 12.7% | |
| Other (as described) | LAB SUPPLIES AND EQUIPM | $8,954,000 | $8,048,000 | $906,000 | - | 10.0% |
| Occupancy | $6,055,000 | $5,800,000 | $242,000 | $13,000 | 6.7% | |
| Pay: officers, directors, trustees, key employees | $4,224,000 | $1,924,000 | $1,948,000 | $352,000 | 4.7% | |
| Other employee benefits | $4,172,000 | $2,874,000 | $1,134,000 | $164,000 | 4.6% | |
| Fees: other services | $3,933,000 | $1,976,000 | $1,706,000 | $251,000 | 4.4% | |
| Pension plan contributions | $2,319,000 | $1,921,000 | $376,000 | $22,000 | 2.6% | |
| Information technology | $2,010,000 | $389,000 | $1,582,000 | $39,000 | 2.2% | |
| Payroll taxes | $1,908,000 | $1,461,000 | $405,000 | $42,000 | 2.1% | |
| Other (as described) | STIPENDS | $1,665,000 | $1,658,000 | $7,000 | - | 1.9% |
| Interest | $1,326,000 | $1,267,000 | $56,000 | $3,000 | 1.5% | |
| Fees: legal | $859,000 | $7,000 | $852,000 | - | 1.0% | |
| Office expenses | $738,000 | $262,000 | $460,000 | $16,000 | 0.8% | |
| Other (as described) | TUITION, HONRARIUM, AND | $650,000 | $590,000 | $20,000 | $40,000 | 0.7% |
| Fees: investment management | $548,000 | - | $548,000 | - | 0.6% | |
| Travel | $531,000 | $450,000 | $67,000 | $14,000 | 0.6% | |
| All other expenses | $361,000 | $269,000 | $79,000 | $13,000 | 0.4% | |
| Insurance | $335,000 | - | $335,000 | - | 0.4% | |
| Fees: lobbying | $233,000 | - | $233,000 | - | 0.3% | |
| Fees: accounting | $174,000 | - | $174,000 | - | 0.2% | |
| Advertising and promotion | $69,000 | - | $69,000 | - | 0.1% | |
| Conferences, conventions and meetings | $6,000 | $3,000 | $3,000 | - | 0.0% | |
| Total | $89,910,000 | 100% |
2024 · Form 990 · $93,862,000 spent · pay $38,912,000 · grants $0 · events $9,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $26,241,000 | $20,278,000 | $5,282,000 | $681,000 | 28.0% | |
| Other (as described) | SUBAWARDS | $17,578,000 | $17,578,000 | $0 | $0 | 18.7% |
| Other (as described) | LAB SUPPLIES AND EQUIPM | $10,014,000 | $9,266,000 | $748,000 | $0 | 10.7% |
| Depreciation and depletion | $8,620,000 | $7,560,000 | $1,002,000 | $58,000 | 9.2% | |
| Occupancy | $5,123,000 | $4,533,000 | $555,000 | $35,000 | 5.5% | |
| Other employee benefits | $4,258,000 | $2,959,000 | $1,147,000 | $152,000 | 4.5% | |
| Pay: officers, directors, trustees, key employees | $4,229,000 | $1,865,000 | $2,025,000 | $339,000 | 4.5% | |
| Fees: other services | $4,228,000 | $2,081,000 | $1,772,000 | $375,000 | 4.5% | |
| Pension plan contributions | $2,263,000 | $1,905,000 | $324,000 | $34,000 | 2.4% | |
| Payroll taxes | $1,921,000 | $1,484,000 | $387,000 | $50,000 | 2.0% | |
| Other (as described) | STIPENDS | $1,753,000 | $1,720,000 | $33,000 | $0 | 1.9% |
| Information technology | $1,495,000 | $298,000 | $1,172,000 | $25,000 | 1.6% | |
| Fees: legal | $1,443,000 | - | $1,442,000 | $1,000 | 1.5% | |
| Interest | $1,331,000 | $1,167,000 | $155,000 | $9,000 | 1.4% | |
| Fees: investment management | $587,000 | - | $587,000 | - | 0.6% | |
| Travel | $522,000 | $410,000 | $93,000 | $19,000 | 0.6% | |
| Office expenses | $510,000 | $271,000 | $220,000 | $19,000 | 0.5% | |
| Other (as described) | TUITION, HONRARIUM, AND | $448,000 | $316,000 | $85,000 | $47,000 | 0.5% |
| Insurance | $337,000 | $3,000 | $334,000 | - | 0.4% | |
| All other expenses | $303,000 | $250,000 | $43,000 | $10,000 | 0.3% | |
| Fees: lobbying | $272,000 | - | $272,000 | - | 0.3% | |
| Fees: accounting | $202,000 | - | $202,000 | - | 0.2% | |
| Advertising and promotion | $175,000 | - | $175,000 | - | 0.2% | |
| Conferences, conventions and meetings | $9,000 | $7,000 | $2,000 | - | 0.0% | |
| Total | $93,862,000 | 100% |
2023 · Form 990 · $91,822,000 spent · pay $35,855,000 · grants $0 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $24,759,000 | $19,218,000 | $4,959,000 | $582,000 | 27.0% | |
| Other (as described) | SUBAWARDS | $19,459,000 | $19,459,000 | - | - | 21.2% |
| Other (as described) | LAB SUPPLIES AND EQUIPM | $11,442,000 | $10,843,000 | $599,000 | - | 12.5% |
| Depreciation and depletion | $7,549,000 | $6,620,000 | $878,000 | $51,000 | 8.2% | |
| Occupancy | $4,702,000 | $4,453,000 | $215,000 | $34,000 | 5.1% | |
| Fees: other services | $4,360,000 | $2,398,000 | $1,630,000 | $332,000 | 4.7% | |
| Other employee benefits | $4,348,000 | $3,134,000 | $1,077,000 | $137,000 | 4.7% | |
| Pay: officers, directors, trustees, key employees | $2,884,000 | $1,285,000 | $1,287,000 | $312,000 | 3.1% | |
| Pension plan contributions | $2,147,000 | $1,770,000 | $350,000 | $27,000 | 2.3% | |
| Payroll taxes | $1,717,000 | $1,333,000 | $344,000 | $40,000 | 1.9% | |
| Other (as described) | STIPENDS | $1,425,000 | $1,425,000 | - | - | 1.6% |
| Information technology | $1,416,000 | $289,000 | $1,107,000 | $20,000 | 1.5% | |
| Fees: legal | $1,329,000 | - | $1,329,000 | - | 1.4% | |
| Interest | $1,323,000 | $1,160,000 | $154,000 | $9,000 | 1.4% | |
| Fees: investment management | $591,000 | - | $591,000 | - | 0.6% | |
| Travel | $554,000 | $467,000 | $78,000 | $9,000 | 0.6% | |
| Office expenses | $387,000 | $279,000 | $94,000 | $14,000 | 0.4% | |
| Insurance | $298,000 | - | $298,000 | - | 0.3% | |
| Fees: lobbying | $268,000 | - | $268,000 | - | 0.3% | |
| Other (as described) | TUITION, HONRARIUM, AND | $258,000 | $237,000 | $21,000 | - | 0.3% |
| Fees: accounting | $215,000 | - | $215,000 | - | 0.2% | |
| All other expenses | $206,000 | $144,000 | $44,000 | $18,000 | 0.2% | |
| Advertising and promotion | $185,000 | $1,000 | $179,000 | $5,000 | 0.2% | |
| Total | $91,822,000 | 100% |
2022 · Form 990 · $85,062,000 spent · pay $32,639,000 · grants $0 · events $0
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $22,428,000 | $17,670,000 | $4,252,000 | $506,000 | 26.4% | |
| Other (as described) | SUBAWARDS | $19,491,000 | $19,491,000 | - | - | 22.9% |
| Other (as described) | LAB SUPPLIES AND EQUIPM | $11,202,000 | $10,757,000 | $445,000 | - | 13.2% |
| Depreciation and depletion | $6,683,000 | $5,861,000 | $777,000 | $45,000 | 7.9% | |
| Occupancy | $4,870,000 | $4,563,000 | $272,000 | $35,000 | 5.7% | |
| Other employee benefits | $4,166,000 | $3,083,000 | $950,000 | $133,000 | 4.9% | |
| Fees: other services | $3,063,000 | $955,000 | $1,545,000 | $563,000 | 3.6% | |
| Pay: officers, directors, trustees, key employees | $2,536,000 | $1,220,000 | $1,126,000 | $190,000 | 3.0% | |
| Pension plan contributions | $1,981,000 | $1,651,000 | $301,000 | $29,000 | 2.3% | |
| Payroll taxes | $1,528,000 | $1,204,000 | $290,000 | $34,000 | 1.8% | |
| Interest | $1,326,000 | $1,163,000 | $154,000 | $9,000 | 1.6% | |
| Information technology | $1,314,000 | $281,000 | $1,020,000 | $13,000 | 1.5% | |
| Fees: legal | $1,154,000 | - | $1,154,000 | - | 1.4% | |
| Other (as described) | STIPENDS | $1,110,000 | $1,110,000 | - | - | 1.3% |
| Fees: investment management | $553,000 | - | $553,000 | - | 0.7% | |
| Insurance | $341,000 | $1,000 | $340,000 | - | 0.4% | |
| Travel | $309,000 | $249,000 | $48,000 | $12,000 | 0.4% | |
| Office expenses | $266,000 | $194,000 | $62,000 | $10,000 | 0.3% | |
| All other expenses | $223,000 | $196,000 | $23,000 | $4,000 | 0.3% | |
| Other (as described) | TUITION, HONRARIUM, AND | $168,000 | $148,000 | $8,000 | $12,000 | 0.2% |
| Fees: accounting | $147,000 | - | $147,000 | - | 0.2% | |
| Advertising and promotion | $115,000 | $3,000 | $76,000 | $36,000 | 0.1% | |
| Fees: lobbying | $88,000 | - | $88,000 | - | 0.1% | |
| Total | $85,062,000 | 100% |
2021 · Form 990 · $69,091,000 spent · pay $30,517,000 · grants $0 · events $5,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $21,070,000 | $16,036,000 | $4,631,000 | $403,000 | 30.5% | |
| Other (as described) | LAB SUPPLIES AND EQUIPM | $9,494,000 | $9,008,000 | $486,000 | - | 13.7% |
| Other (as described) | SUBAWARDS | $9,217,000 | $9,203,000 | $14,000 | - | 13.3% |
| Depreciation and depletion | $6,709,000 | $5,884,000 | $780,000 | $45,000 | 9.7% | |
| Occupancy | $4,317,000 | $3,966,000 | $321,000 | $30,000 | 6.2% | |
| Other employee benefits | $3,317,000 | $2,329,000 | $860,000 | $128,000 | 4.8% | |
| Fees: other services | $3,216,000 | $1,784,000 | $1,122,000 | $310,000 | 4.7% | |
| Pay: officers, directors, trustees, key employees | $2,724,000 | $1,177,000 | $1,246,000 | $301,000 | 3.9% | |
| Pension plan contributions | $1,924,000 | $1,566,000 | $349,000 | $9,000 | 2.8% | |
| Payroll taxes | $1,482,000 | $1,128,000 | $326,000 | $28,000 | 2.1% | |
| Interest | $1,323,000 | $1,160,000 | $154,000 | $9,000 | 1.9% | |
| Information technology | $969,000 | $226,000 | $724,000 | $19,000 | 1.4% | |
| Other (as described) | STIPENDS | $884,000 | $884,000 | - | - | 1.3% |
| Fees: legal | $756,000 | - | $756,000 | - | 1.1% | |
| Fees: investment management | $600,000 | - | $600,000 | - | 0.9% | |
| Insurance | $278,000 | - | $278,000 | - | 0.4% | |
| Office expenses | $221,000 | $152,000 | $64,000 | $5,000 | 0.3% | |
| All other expenses | $170,000 | $75,000 | $95,000 | - | 0.2% | |
| Fees: accounting | $135,000 | - | $135,000 | - | 0.2% | |
| Fees: lobbying | $88,000 | - | $88,000 | - | 0.1% | |
| Travel | $72,000 | $72,000 | - | - | 0.1% | |
| Other (as described) | TUITION, HONRARIUM, AND | $68,000 | $49,000 | $17,000 | $2,000 | 0.1% |
| Advertising and promotion | $54,000 | $4,000 | $50,000 | - | 0.1% | |
| Conferences, conventions and meetings | $3,000 | - | $3,000 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $0 | $2,000 | reported apart | |||
| Total | $69,091,000 | 100% |
2020 · Form 990 · $68,907,000 spent · pay $31,420,000 · grants $0 · events $139,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $21,179,000 | $15,720,000 | $4,958,000 | $501,000 | 30.7% | |
| Other (as described) | Subawards | $9,185,000 | $9,165,000 | $20,000 | $0 | 13.3% |
| Other (as described) | Lab supplies and equipment agreements | $8,808,000 | $8,320,000 | $488,000 | $0 | 12.8% |
| Depreciation and depletion | $6,785,000 | $5,950,000 | $789,000 | $46,000 | 9.8% | |
| Occupancy | $4,279,000 | $3,776,000 | $474,000 | $29,000 | 6.2% | |
| Other employee benefits | $3,812,000 | $2,596,000 | $1,063,000 | $153,000 | 5.5% | |
| Pay: officers, directors, trustees, key employees | $2,938,000 | $1,221,000 | $1,416,000 | $301,000 | 4.3% | |
| Fees: other services | $2,872,000 | $1,744,000 | $904,000 | $224,000 | 4.2% | |
| Pension plan contributions | $1,951,000 | $1,544,000 | $387,000 | $20,000 | 2.8% | |
| Payroll taxes | $1,540,000 | $1,143,000 | $361,000 | $36,000 | 2.2% | |
| Interest | $1,336,000 | $1,172,000 | $155,000 | $9,000 | 1.9% | |
| Information technology | $1,111,000 | $182,000 | $905,000 | $24,000 | 1.6% | |
| Fees: legal | $733,000 | $0 | $733,000 | $0 | 1.1% | |
| Other (as described) | Stipends | $720,000 | $713,000 | $7,000 | $0 | 1.0% |
| Fees: investment management | $513,000 | $0 | $513,000 | $0 | 0.7% | |
| All other expenses | $295,000 | $187,000 | $108,000 | $0 | 0.4% | |
| Insurance | $263,000 | $0 | $263,000 | $0 | 0.4% | |
| Fees: accounting | $148,000 | $0 | $148,000 | $0 | 0.2% | |
| Office expenses | $128,000 | $90,000 | $31,000 | $7,000 | 0.2% | |
| Other (as described) Event | Tuition, Honorarium, and Events | $126,000 | $91,000 | $22,000 | $13,000 | 0.2% |
| Fees: lobbying | $88,000 | $0 | $88,000 | $0 | 0.1% | |
| Travel | $58,000 | $36,000 | $12,000 | $10,000 | 0.1% | |
| Advertising and promotion | $39,000 | $7,000 | $32,000 | $0 | 0.1% | |
| Fundraising events Event | direct expenses; gross income $1,000 | $13,000 | reported apart | |||
| Total | $68,907,000 | 100% |
2019 · Form 990 · $68,702,000 spent · pay $32,156,000 · grants $0 · events $505,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $21,939,000 | $16,391,000 | $4,998,000 | $550,000 | 31.9% | |
| Other (as described) | Subawards | $9,219,000 | $9,201,000 | $18,000 | $0 | 13.4% |
| Other (as described) | Lab supplies and equipment agreements | $8,349,000 | $7,815,000 | $534,000 | $0 | 12.2% |
| Depreciation and depletion | $6,826,000 | $5,986,000 | $794,000 | $46,000 | 9.9% | |
| Occupancy | $4,137,000 | $3,658,000 | $451,000 | $28,000 | 6.0% | |
| Other employee benefits | $4,126,000 | $2,786,000 | $1,174,000 | $166,000 | 6.0% | |
| Pay: officers, directors, trustees, key employees | $2,637,000 | $1,101,000 | $1,278,000 | $258,000 | 3.8% | |
| Pension plan contributions | $1,948,000 | $1,544,000 | $375,000 | $29,000 | 2.8% | |
| Fees: other services | $1,938,000 | $1,007,000 | $880,000 | $51,000 | 2.8% | |
| Payroll taxes | $1,506,000 | $1,125,000 | $343,000 | $38,000 | 2.2% | |
| Interest | $1,326,000 | $1,163,000 | $154,000 | $9,000 | 1.9% | |
| Office expenses | $1,006,000 | $726,000 | $248,000 | $32,000 | 1.5% | |
| Information technology | $827,000 | $150,000 | $670,000 | $7,000 | 1.2% | |
| Fees: investment management | $484,000 | $0 | $484,000 | $0 | 0.7% | |
| Fees: legal | $460,000 | $0 | $460,000 | $0 | 0.7% | |
| Travel | $444,000 | $316,000 | $108,000 | $20,000 | 0.6% | |
| Other (as described) | Stipends | $386,000 | $386,000 | $0 | $0 | 0.6% |
| All other expenses | $357,000 | $255,000 | $102,000 | $0 | 0.5% | |
| Other (as described) Event | Tuition, honorarium, and events | $266,000 | $105,000 | $157,000 | $4,000 | 0.4% |
| Insurance | $259,000 | $0 | $259,000 | $0 | 0.4% | |
| Fees: accounting | $138,000 | $0 | $138,000 | $0 | 0.2% | |
| Fees: lobbying | $81,000 | $0 | $81,000 | $0 | 0.1% | |
| Advertising and promotion | $43,000 | $0 | $42,000 | $1,000 | 0.1% | |
| Fundraising events Event | direct expenses; gross income $569,000 | $239,000 | reported apart | |||
| Total | $68,702,000 | 100% |
2018 · Form 990 · $69,520,000 spent · pay $30,493,000 · grants $0 · events $328,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $19,989,000 | $14,776,000 | $4,664,000 | $549,000 | 28.8% | |
| Other (as described) | Subawards | $12,065,000 | $12,065,000 | $0 | $0 | 17.4% |
| Other (as described) | Lab supplies and equipment agreements | $7,542,000 | $7,064,000 | $478,000 | $0 | 10.8% |
| Depreciation and depletion | $7,053,000 | $6,186,000 | $820,000 | $47,000 | 10.1% | |
| Other employee benefits | $4,739,000 | $3,230,000 | $1,322,000 | $187,000 | 6.8% | |
| Occupancy | $4,247,000 | $3,793,000 | $424,000 | $30,000 | 6.1% | |
| Fees: other services | $2,571,000 | $1,826,000 | $588,000 | $157,000 | 3.7% | |
| Pay: officers, directors, trustees, key employees | $2,453,000 | $1,008,000 | $1,205,000 | $240,000 | 3.5% | |
| Pension plan contributions | $1,904,000 | $1,492,000 | $379,000 | $33,000 | 2.7% | |
| Payroll taxes | $1,408,000 | $1,041,000 | $328,000 | $39,000 | 2.0% | |
| Interest | $1,332,000 | $1,168,000 | $155,000 | $9,000 | 1.9% | |
| Information technology | $833,000 | $185,000 | $584,000 | $64,000 | 1.2% | |
| Office expenses | $728,000 | $567,000 | $121,000 | $40,000 | 1.0% | |
| Fees: legal | $469,000 | $0 | $469,000 | $0 | 0.7% | |
| Travel | $446,000 | $346,000 | $80,000 | $20,000 | 0.6% | |
| Other (as described) | Stipends | $322,000 | $322,000 | $0 | $0 | 0.5% |
| All other expenses | $316,000 | $102,000 | $214,000 | $0 | 0.5% | |
| Fees: investment management | $299,000 | - | $299,000 | - | 0.4% | |
| Insurance | $260,000 | $0 | $260,000 | $0 | 0.4% | |
| Advertising and promotion | $191,000 | $0 | $191,000 | $0 | 0.3% | |
| Other (as described) Event | Tuition, honorarium, and events | $179,000 | $117,000 | $62,000 | $0 | 0.3% |
| Fees: accounting | $91,000 | $0 | $91,000 | $0 | 0.1% | |
| Fees: lobbying | $83,000 | $0 | $83,000 | $0 | 0.1% | |
| Fundraising events Event | direct expenses; gross income $246,000 | $149,000 | reported apart | |||
| Total | $69,520,000 | 100% |
2017 · Form 990 · $72,233,000 spent · pay $28,346,000 · grants $0 · events $485,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $19,746,000 | $14,090,000 | $5,372,000 | $284,000 | 27.3% | |
| Other (as described) | Subawards | $15,989,000 | $15,989,000 | $0 | $0 | 22.1% |
| Other (as described) | Lab Supplies and Equipment Agreement | $9,307,000 | $8,818,000 | $489,000 | $0 | 12.9% |
| Depreciation and depletion | $7,211,000 | $6,324,000 | $839,000 | $48,000 | 10.0% | |
| Occupancy | $4,041,000 | $3,612,000 | $401,000 | $28,000 | 5.6% | |
| Other employee benefits | $3,051,000 | $2,177,000 | $830,000 | $44,000 | 4.2% | |
| Pay: officers, directors, trustees, key employees | $2,143,000 | $1,529,000 | $583,000 | $31,000 | 3.0% | |
| Fees: other services | $2,062,000 | $1,544,000 | $19,000 | $499,000 | 2.9% | |
| Pension plan contributions | $2,031,000 | $1,449,000 | $553,000 | $29,000 | 2.8% | |
| Payroll taxes | $1,375,000 | $981,000 | $374,000 | $20,000 | 1.9% | |
| Interest | $1,258,000 | $1,103,000 | $146,000 | $9,000 | 1.7% | |
| Office expenses | $924,000 | $610,000 | $260,000 | $54,000 | 1.3% | |
| Information technology | $893,000 | $214,000 | $616,000 | $63,000 | 1.2% | |
| Fees: investment management | $534,000 | - | $534,000 | - | 0.7% | |
| Fees: legal | $395,000 | $0 | $395,000 | $0 | 0.5% | |
| Travel | $385,000 | $276,000 | $76,000 | $33,000 | 0.5% | |
| All other expenses | $269,000 | $0 | $61,000 | $208,000 | 0.4% | |
| Insurance | $268,000 | $0 | $268,000 | $0 | 0.4% | |
| Fees: accounting | $138,000 | $0 | $138,000 | $0 | 0.2% | |
| Advertising and promotion | $136,000 | $0 | $136,000 | $0 | 0.2% | |
| Fees: lobbying | $77,000 | $0 | $77,000 | $0 | 0.1% | |
| Fundraising events Event | direct expenses; gross income $249,000 | $485,000 | reported apart | |||
| Total | $72,233,000 | 100% |
2015 · Form 990 · $59,156,000 spent · pay $26,233,000 · grants $0 · events $156,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $17,753,000 | $12,495,000 | $5,161,000 | $97,000 | 30.0% | |
| Other (as described) | Subawards | $8,961,000 | $8,961,000 | $0 | $0 | 15.1% |
| Other (as described) | Lab supplies and equipment agreements | $7,512,000 | $6,858,000 | $644,000 | $10,000 | 12.7% |
| Depreciation and depletion | $6,858,000 | $6,436,000 | $372,000 | $50,000 | 11.6% | |
| Occupancy | $3,774,000 | $3,550,000 | $201,000 | $23,000 | 6.4% | |
| Other employee benefits | $3,012,000 | $2,120,000 | $876,000 | $16,000 | 5.1% | |
| Pay: officers, directors, trustees, key employees | $2,334,000 | $390,000 | $1,926,000 | $18,000 | 3.9% | |
| Pension plan contributions | $1,895,000 | $1,334,000 | $551,000 | $10,000 | 3.2% | |
| Interest | $1,683,000 | $1,579,000 | $92,000 | $12,000 | 2.8% | |
| Fees: other services | $1,651,000 | $231,000 | $1,052,000 | $368,000 | 2.8% | |
| Payroll taxes | $1,239,000 | $872,000 | $360,000 | $7,000 | 2.1% | |
| Travel | $376,000 | $261,000 | $113,000 | $2,000 | 0.6% | |
| Fees: legal | $371,000 | - | $371,000 | - | 0.6% | |
| Fees: investment management | $366,000 | - | $366,000 | - | 0.6% | |
| Office expenses | $313,000 | $18,000 | $292,000 | $3,000 | 0.5% | |
| All other expenses | $308,000 | $0 | $308,000 | $0 | 0.5% | |
| Information technology | $277,000 | $138,000 | $127,000 | $12,000 | 0.5% | |
| Insurance | $246,000 | - | $246,000 | - | 0.4% | |
| Fees: accounting | $87,000 | - | $87,000 | - | 0.1% | |
| Advertising and promotion | $73,000 | $16,000 | $57,000 | $0 | 0.1% | |
| Fees: lobbying | $67,000 | - | $67,000 | - | 0.1% | |
| Other (as described) | Allocation of O & M exp | $0 | $1,246,000 | -$1,246,000 | - | 0.0% |
| Fundraising events Event | direct expenses; gross income $110,000 | $156,000 | reported apart | |||
| Total | $59,156,000 | 100% |
2014 · Form 990 · $57,908,000 spent · pay $27,573,000 · grants $0 · events $239,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $18,476,000 | $13,176,000 | $5,113,000 | $187,000 | 31.9% | |
| Other (as described) | Subawards | $8,153,000 | $8,153,000 | $0 | $0 | 14.1% |
| Depreciation and depletion | $5,550,000 | $5,219,000 | $297,000 | $34,000 | 9.6% | |
| Other (as described) | Lab supplies and equipment agreements | $5,343,000 | $4,235,000 | $1,082,000 | $26,000 | 9.2% |
| Occupancy | $4,751,000 | $841,000 | $3,910,000 | $0 | 8.2% | |
| Other employee benefits | $3,455,000 | $2,376,000 | $1,037,000 | $42,000 | 6.0% | |
| Pay: officers, directors, trustees, key employees | $2,621,000 | $351,000 | $2,181,000 | $89,000 | 4.5% | |
| Fees: other services | $2,022,000 | $870,000 | $1,105,000 | $47,000 | 3.5% | |
| Pension plan contributions | $1,841,000 | $1,198,000 | $624,000 | $19,000 | 3.2% | |
| Payroll taxes | $1,180,000 | $768,000 | $400,000 | $12,000 | 2.0% | |
| All other expenses | $1,101,000 | $678,000 | $327,000 | $96,000 | 1.9% | |
| Interest | $898,000 | $808,000 | $81,000 | $9,000 | 1.6% | |
| Office expenses | $479,000 | $64,000 | $396,000 | $19,000 | 0.8% | |
| Travel | $439,000 | $237,000 | $191,000 | $11,000 | 0.8% | |
| Fees: legal | $424,000 | $0 | $424,000 | $0 | 0.7% | |
| Fees: investment management | $376,000 | $0 | $376,000 | $0 | 0.6% | |
| Information technology | $310,000 | $189,000 | $120,000 | $1,000 | 0.5% | |
| Insurance | $270,000 | $0 | $270,000 | $0 | 0.5% | |
| Fees: lobbying | $91,000 | $0 | $91,000 | $0 | 0.2% | |
| Advertising and promotion | $66,000 | $0 | $52,000 | $14,000 | 0.1% | |
| Fees: accounting | $56,000 | $0 | $56,000 | $0 | 0.1% | |
| Conferences, conventions and meetings | $6,000 | $1,000 | $5,000 | $0 | 0.0% | |
| Other (as described) | Allocation of Operations & Maintenance expenses | $0 | $6,101,000 | -$6,178,000 | $77,000 | 0.0% |
| Fundraising events Event | direct expenses; gross income $140,000 | $233,000 | reported apart | |||
| Total | $57,908,000 | 100% |
2013 · Form 990 · $57,593,000 spent · pay $29,371,000 · grants $0 · events $276,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $19,619,000 | $14,218,000 | $5,145,000 | $256,000 | 34.1% | |
| Other (as described) | Subcontracts | $6,938,000 | $6,938,000 | $0 | $0 | 12.0% |
| Depreciation and depletion | $5,526,000 | $5,187,000 | $305,000 | $34,000 | 9.6% | |
| Occupancy | $5,145,000 | $2,118,000 | $3,025,000 | $2,000 | 8.9% | |
| Other (as described) | Lab supplies and equipment maintenance agreements | $5,096,000 | $4,266,000 | $829,000 | $1,000 | 8.8% |
| Other employee benefits | $3,911,000 | $2,701,000 | $1,156,000 | $54,000 | 6.8% | |
| Pension plan contributions | $2,287,000 | $1,542,000 | $718,000 | $27,000 | 4.0% | |
| Fees: other services | $2,260,000 | $516,000 | $1,691,000 | $53,000 | 3.9% | |
| Pay: officers, directors, trustees, key employees | $2,220,000 | $343,000 | $1,877,000 | $0 | 3.9% | |
| Payroll taxes | $1,334,000 | $899,000 | $419,000 | $16,000 | 2.3% | |
| All other expenses | $882,000 | $403,000 | $358,000 | $121,000 | 1.5% | |
| Information technology | $563,000 | $97,000 | $453,000 | $13,000 | 1.0% | |
| Fees: legal | $508,000 | $0 | $508,000 | $0 | 0.9% | |
| Office expenses | $426,000 | $98,000 | $313,000 | $15,000 | 0.7% | |
| Travel | $225,000 | $118,000 | $102,000 | $5,000 | 0.4% | |
| Insurance | $225,000 | $0 | $225,000 | $0 | 0.4% | |
| Fees: lobbying | $138,000 | $0 | $138,000 | $0 | 0.2% | |
| Fees: accounting | $101,000 | $0 | $101,000 | $0 | 0.2% | |
| Advertising and promotion | $92,000 | $1,000 | $9,000 | $82,000 | 0.2% | |
| Conferences, conventions and meetings | $68,000 | $47,000 | $21,000 | $0 | 0.1% | |
| Interest | $29,000 | $0 | $29,000 | $0 | 0.1% | |
| Other (as described) | Allocation of Operations & Maintenance expenses reported in C | $0 | $5,319,000 | -$5,400,000 | $81,000 | 0.0% |
| Fundraising events Event | direct expenses; gross income $112,000 | $208,000 | reported apart | |||
| Total | $57,593,000 | 100% |
2012 · Form 990 · $62,072,000 spent · pay $30,151,000 · grants $0 · events $155,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $20,119,000 | $14,698,000 | $5,084,000 | $337,000 | 32.4% | |
| Other (as described) | Subcontracts | $8,301,000 | $8,301,000 | $0 | $0 | 13.4% |
| Other (as described) | Lab supplies and equipment maintenance agreements | $6,374,000 | $4,956,000 | $1,418,000 | $0 | 10.3% |
| Occupancy | $5,953,000 | $166,000 | $5,787,000 | - | 9.6% | |
| Depreciation and depletion | $5,940,000 | - | $5,940,000 | - | 9.6% | |
| Other employee benefits | $4,000,000 | $2,785,000 | $1,145,000 | $70,000 | 6.4% | |
| Pension plan contributions | $2,452,000 | $1,681,000 | $734,000 | $37,000 | 4.0% | |
| Pay: officers, directors, trustees, key employees | $2,196,000 | $470,000 | $1,726,000 | $0 | 3.5% | |
| Fees: other services | $1,745,000 | $543,000 | $1,162,000 | $40,000 | 2.8% | |
| Payroll taxes | $1,384,000 | $949,000 | $414,000 | $21,000 | 2.2% | |
| All other expenses | $1,113,000 | $506,000 | $560,000 | $47,000 | 1.8% | |
| Information technology | $662,000 | $86,000 | $565,000 | $11,000 | 1.1% | |
| Office expenses | $436,000 | $71,000 | $354,000 | $11,000 | 0.7% | |
| Travel | $337,000 | $221,000 | $105,000 | $11,000 | 0.5% | |
| Fees: legal | $314,000 | - | $311,000 | $3,000 | 0.5% | |
| Insurance | $218,000 | - | $218,000 | - | 0.4% | |
| Fees: lobbying | $181,000 | - | $181,000 | - | 0.3% | |
| Fees: investment management | $97,000 | - | $97,000 | - | 0.2% | |
| Conferences, conventions and meetings | $94,000 | $72,000 | $21,000 | $1,000 | 0.2% | |
| Fees: accounting | $87,000 | - | $87,000 | - | 0.1% | |
| Interest | $35,000 | - | $35,000 | - | 0.1% | |
| Advertising and promotion | $34,000 | - | $29,000 | $5,000 | 0.1% | |
| Other (as described) | Allocation of Operations and Maintenance | $0 | $8,194,000 | -$8,284,000 | $90,000 | 0.0% |
| Other (as described) | Allocation of Depreciation reported in C | $0 | $5,563,000 | -$5,601,000 | $38,000 | 0.0% |
| Fundraising events Event | direct expenses; gross income - | $61,000 | reported apart | |||
| Total | $62,072,000 | 100% |
2011 · Form 990 · $60,061,000 spent · pay $29,496,000 · grants $0 · events $256,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $19,916,000 | $14,761,000 | $4,827,000 | $328,000 | 33.2% | |
| Other (as described) | Subcontracts | $10,117,000 | $10,117,000 | $0 | $0 | 16.8% |
| Other (as described) | Lab supplies and equpment maintenance agreements | $6,099,000 | $5,564,000 | $530,000 | $5,000 | 10.2% |
| Occupancy | $4,295,000 | $37,000 | $4,258,000 | - | 7.2% | |
| Depreciation and depletion | $4,121,000 | - | $4,121,000 | - | 6.9% | |
| Other employee benefits | $3,832,000 | $2,735,000 | $1,032,000 | $65,000 | 6.4% | |
| Pension plan contributions | $2,406,000 | $1,655,000 | $715,000 | $36,000 | 4.0% | |
| Fees: other services | $2,223,000 | $1,089,000 | $993,000 | $141,000 | 3.7% | |
| Pay: officers, directors, trustees, key employees | $1,969,000 | $124,000 | $1,845,000 | $0 | 3.3% | |
| All other expenses | $1,451,000 | $854,000 | $419,000 | $178,000 | 2.4% | |
| Payroll taxes | $1,373,000 | $944,000 | $408,000 | $21,000 | 2.3% | |
| Information technology | $646,000 | $173,000 | $461,000 | $12,000 | 1.1% | |
| Office expenses | $397,000 | $69,000 | $317,000 | $11,000 | 0.7% | |
| Travel | $293,000 | $191,000 | $94,000 | $8,000 | 0.5% | |
| Fees: lobbying | $237,000 | - | $237,000 | - | 0.4% | |
| Fees: legal | $198,000 | - | $198,000 | - | 0.3% | |
| Insurance | $198,000 | - | $198,000 | - | 0.3% | |
| Fees: investment management | $89,000 | - | $89,000 | - | 0.1% | |
| Fees: accounting | $83,000 | - | $83,000 | - | 0.1% | |
| Conferences, conventions and meetings | $65,000 | $46,000 | $19,000 | - | 0.1% | |
| Advertising and promotion | $33,000 | $1,000 | $32,000 | - | 0.1% | |
| Interest | $20,000 | - | $20,000 | - | 0.0% | |
| Other (as described) | Allocation of Operations and Maintenance reported in C | $0 | $6,717,000 | -$6,791,000 | $74,000 | 0.0% |
| Other (as described) | Allocation of Depreciation expense reported in C | $0 | $3,915,000 | -$3,936,000 | $21,000 | 0.0% |
| Fundraising events Event | direct expenses; gross income - | $191,000 | reported apart | |||
| Total | $60,061,000 | 100% |
2010 · Form 990 · $56,338,000 spent · pay $28,280,000 · grants $0 · events $97,000
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $19,826,000 | $14,277,000 | $5,227,000 | $322,000 | 35.2% | |
| Other (as described) | Subcontracts | $9,838,000 | $9,838,000 | $0 | $0 | 17.5% |
| Other (as described) | Lab supplies and equipment maintenance agreements | $5,778,000 | $4,833,000 | $944,000 | $1,000 | 10.3% |
| Depreciation and depletion | $3,730,000 | - | $3,730,000 | - | 6.6% | |
| Occupancy | $3,455,000 | $13,000 | $3,442,000 | - | 6.1% | |
| Other employee benefits | $3,342,000 | $2,326,000 | $958,000 | $58,000 | 5.9% | |
| Pension plan contributions | $2,144,000 | $1,469,000 | $643,000 | $32,000 | 3.8% | |
| All other expenses | $1,639,000 | $952,000 | $624,000 | $63,000 | 2.9% | |
| Pay: officers, directors, trustees, key employees | $1,622,000 | $300,000 | $1,322,000 | $0 | 2.9% | |
| Fees: other services | $1,533,000 | $894,000 | $587,000 | $52,000 | 2.7% | |
| Payroll taxes | $1,346,000 | $922,000 | $404,000 | $20,000 | 2.4% | |
| Information technology | $598,000 | $129,000 | $462,000 | $7,000 | 1.1% | |
| Office expenses | $363,000 | $58,000 | $293,000 | $12,000 | 0.6% | |
| Travel | $303,000 | $154,000 | $138,000 | $11,000 | 0.5% | |
| Fees: legal | $276,000 | - | $220,000 | $56,000 | 0.5% | |
| Insurance | $196,000 | - | $196,000 | - | 0.3% | |
| Fees: lobbying | $130,000 | - | $130,000 | - | 0.2% | |
| Conferences, conventions and meetings | $97,000 | $56,000 | $41,000 | - | 0.2% | |
| Fees: investment management | $82,000 | - | $82,000 | - | 0.1% | |
| Fees: accounting | $78,000 | - | $78,000 | - | 0.1% | |
| Advertising and promotion | $25,000 | - | $25,000 | - | 0.0% | |
| Interest | $1,000 | - | $1,000 | - | 0.0% | |
| Other (as described) | Allocation of Operations and Maintenance reported in C | $0 | $5,624,000 | -$5,686,000 | $62,000 | 0.0% |
| Other (as described) | Allocation of Depreciation expense reported in C | $0 | $3,555,000 | -$3,572,000 | $17,000 | 0.0% |
| Other (as described) Event | Allocation of fundraising event expenses | -$64,000 | -$64,000 | $0 | $0 | -0.1% |
| Fundraising events Event | direct expenses; gross income - | $64,000 | reported apart | |||
| Total | $56,338,000 | 100% |
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2026 | $51,286,779 | $0 | 82 |
| 2025 | $39,586,224 | $0 | 61 |
| 2024 | $41,110,685 | $0 | 76 |
| 2023 | $44,778,875 | $0 | 66 |
| 2022 | $47,223,720 | $0 | 78 |
| 2021 | $44,027,605 | -$4,326 | 80 |
| 2020 | $36,200,058 | $0 | 67 |
| 2019 | $42,343,668 | $0 | 69 |
| 2018 | $31,547,023 | $0 | 51 |
| 2017 | $41,777,604 | $153,447 | 67 |
| 2016 | $39,093,773 | $480,026 | 58 |
| 2015 | $24,449,394 | -$480,026 | 44 |
| 2014 | $29,056,785 | $0 | 52 |
| 2013 | $26,923,270 | $0 | 55 |
| 2012 | $26,431,856 | $0 | 50 |
| 2011 | $26,965,430 | $8,878,891 | 51 |
| 2010 | $29,140,462 | $679,595 | 47 |
| 2009 | $37,893,758 | $0 | 56 |
| 2008 | $26,647,313 | $4,091,279 | 39 |
| 2007 | $10,059,222 | $1,044,746 | 30 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | SYNTHETIC DNA-LAUNCHED AND ADJUVANTED ENV IMMUNOGENS FOR HIV - OVERALL SUMMARY A PROTECTIVE VACCINE FOR HIV IS ARGUABLY THE MOST IMPORTANT PREVENTION STRATEGY T | $6,319,573 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | BEAT-HIV: DELANEY COLLABORATORY TO CURE HIV-1 INFECTION BY COMBINATION IMMUNOTHERAPY - SUMMARY CURRENT HIV CURATIVE STRATEGIES HAVE PROVEN INSUFFICIENT TO ERADI | $5,586,045 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INDIVIDUALIZED HIV CURATIVE COMBINATION STRATEGY AGAINST PERSISTENT HIV ON ART - SUMMARY WE HAVE DEMONSTRATED MULTIPLE LINES OF EVIDENCE SUPPORTING THE ROLE FOR | $3,369,553 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | CONSOLIDATED BASIC CANCER RESEARCH PROGRAM | $2,855,437 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING THE EPIGENETIC AND METABOLIC CONTROL OF EBV-EPITHELIAL CANCERS - OVERALL – PROJECT SUMMARY THE OVERALL AIM OF THIS NEW PROGRAM PROJECT (P01) PROPOSAL | $2,411,466 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TRANSCRIPTIONAL REPROGRAMMING IN MELANOMA PLASTICITY - PROJECT SUMMARY/ABSTRACT THIS APPLICATION FOCUSES ON ADVANCED MELANOMA, A HIGHLY AGGRESSIVE TYPE OF SKIN | $1,783,158 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | PARKIN TUMOR SUPPRESSION - PROJECT SUMMARY THE LOSS OF ENDOGENOUS TUMOR SUPPRESSORS IS AN OBLIGATORY STEP IN TUMOR ONSET AND PROGRESSION, BUT THE UNDERLYING MEC | $1,498,878 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | RATIONAL APPROACHES TO MELANOMA THERAPY | $1,279,708 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | GRANT/INVESTIGATING METABOLIC CONTROL OF IMMUNE COLD CCNE1-DRIVEN OVARIAN CANCERS | $1,050,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INVESTIGATION INTO THE ACTIVATION OF MULTIPLE BNAB PRECURSORS USING STRUCTURE-DESIGNED IMMUNOGENS AND IG KNOCK-IN MICE - PROJECT SUMMARY HIV-1 VACCINES THAT CAN | $909,225 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ENHANCED NK CELL-BASED TARGETING OF HIV RESERVOIRS THROUGH ENGAGERS AND ADCC ENGINEERING - SUMMARY ACTIVELY REPLICATING HIV INFECTED CELLS ARE THE SOURCE OF PRO | $889,101 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INVESTIGATING N332-GLYCAN INDEPENDENT V3-GLYCAN ANTIBODIES AS NOVEL TARGETS FOR HIV-1 VACCINE DESIGN - PROJECT SUMMARY / ABSTRACT A VACCINE THAT ELICITS BROADLY | $888,042 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REDIRECTING ANTIBODY EPITOPE SPECIFICITY WITH HIV-1 ENV-BASED IMMUNIZATION - PROJECT SUMMARY THE MAIN BARRIER TO DEVELOPING AN EFFICACIOUS HIV-1 VACCINE IS THE | $887,239 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | STRUCTURAL VACCINOLOGY GUIDED DEVELOPMENT OF A UNIVERSAL COV VACCINE UTILIZING NUCLEIC ACID DELIVERED NANOPARTICLES - PROJECT SUMMARY IN DECEMBER 2019 A NOVEL C | $877,556 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | INVESTIGATING BCAA OXIDATION AND SIGNALING IN MACROPHAGES TO DRIVE ANTI-TUMOR IMMUNITY IN PDAC - PROJECT SUMMARY THE TREATMENT OF PANCREATIC DUCTAL ADENOCARCINO | $780,764 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | DEVELOPMENT OF NOVEL BIOLOGICS TARGETING SIGLEC-7/9 FOR ACTIVATING AND ENGAGING NK CELLS AND MACROPHAGES FOR TREATMENT OF ADVANCED BREAST CANCER | $750,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CELL INTRINSIC AND EXTRINSIC EFFECTS OF ZINC METABOLISM IN THERAPY RESISTANT MELANOMA - PROJECT SUMMARY/ABSTRACT THE ULTIMATE GOAL OF THIS PROPOSAL IS TO ADDRES | $736,226 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | EPITOPE-ENGINEERED HSCS TO PERMIT CAR-T CELL-MEDIATED CD4-DEPLETION FOR HIV CURE - PROJECT SUMMARY HIV CURE HAS BEEN ACHIEVED ALMOST EXCLUSIVELY IN INDIVIDUALS | $707,928 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THERAPEUTIC TARGETING MDSC-MEDIATED IMMUNE SUPPRESSION IN CANCER - PROJECT SUMMARY THE PROMINENT CHANGE IN THE MYELOID COMPARTMENT IN CANCER IS THE EXPANSION OF | $696,515 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REGULATION OF GENE EXPRESSION BY ALTERNATIVE POLYADENYLATION - PROJECT SUMMARY MOST MAMMALIAN GENES HARBOR MULTIPLE CLEAVAGE AND POLYADENYLATION SITES, OR PASS, | $664,842 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | ELUCIDATION OF TARGETABLE MECHANISMS SUSTAINING IMMUNOSUPPRESSIVE NEUTROPHILS IN THE BRAIN TUMOR MICROENVIRONMENT - PROJECT SUMMARY GLIOBLASTOMA (GBM), THE MOST | $651,940 |
| 2026 | National Institute of Standards and Technology | Grant or other assistance | CONGRESSIONALLY-IDENTIFIED PROJECTS 11.617 | PURPOSE: THE WISTAR INSTITUTE SEEKS FUNDING FOR THE PURCHASE AND OPERATION OF EQUIPMENT CAPABLE OF MANUFACTURING AND SCREENING NOVEL LIPID NANOPARTICLE FORMULAT | $619,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | MEPCS (MULTI-EPITOPE PROTEASE CLEAVAGE SITES) VACCINE FOR PROTECTING AGAINST SIV RECTAL TRANSMISSION - SUMMARY NOVEL VACCINE STRATEGIES IS NEEDED TO DEVELOP A S | $616,494 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | CONTROL OF TRANSCRIPTIONAL INTEGRITY BY INTEGRATOR AND PP2A - PROJECT SUMMARY OBJECTIVE: THE OVERALL GOALS OF THIS APPLICATION ARE UNDERSTANDING THE MOLECULAR B | $591,549 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REMODELING OF THE HOST EPIGENOME DURING EBV INFECTION - PROJECT SUMMARY IN EBV+ LYMPHOMAS VIRAL PROTEIN EXPRESSION IS THE ONCOGENIC DRIVER AND PROGRESSIVE FORCE | $570,228 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHARACTERIZING THE SOURCES, MECHANISMS, AND TRANSLATIONAL RELEVANCE OF MICROBIAL TMAO IN DRIVING ANTI-TUMOR IMMUNITY IN PANCREATIC CANCER. - PROJECT SUMMARY THE | $566,752 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | DISSECTING ACRAL MELANOMA CELL STATE-SPECIFIC VULNERABILITIES FOR TARGETED INTERVENTION | $560,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DEVELOPING POTENT HIV-SPECIFIC CAR T CELLS THROUGH OPTIMIZING ANTIGEN SENSITIVITY - PROJECT SUMMARY GIVEN THE INABILITY OF THE IMMUNE RESPONSE TO CONSISTENTLY S | $558,595 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REGULATION OF VIRAL CHROMATIN ARCHITECTURE DURING EBV LATENCY | $548,396 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DESIGN OF THE FIRST MDM2 TARGETING PROTACS FOR TREATMENT OF P53 MUTANT OR DEFICIENT CANCERS - PROJECT SUMMARY / ABSTRACT OUR PROPOSAL FOCUSES ON THE DEVELOPMENT | $547,167 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | CTCF-DEPENDENT MECHANISMS OF ATRX IN NEURONAL DIFFERENTIATION - PROJECT SUMMARY ATRX IS AN EPIGENETIC FACTOR THAT IS MUTATED IN ATRX SYNDROME. ATRX IS REQUIRED | $530,646 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | NEW CONTROL OF ONCOGENE ACTIVATION IN T-CELL LEUKEMIA - PROJECT SUMMARY/ABSTRACT NOTCH1 SIGNALING IS AN IMPORTANT MEDIATOR OF STEM CELL SELF-RENEWAL AND THERAPE | $529,915 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | R-LOOP FUNCTIONS IN NEURONAL GENE EXPRESSION AND GENOME ORGANIZATION - PROJECT SUMMARY THE GOAL OF THIS PROPOSAL IS TO UNCOVER THE MECHANISTIC CONNECTION BETWEE | $515,658 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | INVESTIGATING MECHANISMS CONTROLLING THE DEVELOPMENT OF TIM4+ MACROPHAGES - PROJECT SUMMARY 1. OVERVIEW OF RESEARCH IN THE LABORATORY THERE ARE CURRENTLY TWO FO | $506,550 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | NEXT-GENERATION SINGLE-CELL MULTIOMIC METHODS FOR QUANTIFYING CELLULAR IDENTITY - PROJECT SUMMARY IN MULTICELLULAR ORGANISMS, THE INTERPLAY BETWEEN EPIGENETIC A | $506,550 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | NEUTRALIZING PERSISTENT IFN-I TO IMPROVE HIV-SPECIFIC CAR T CELL THERAPY - PROJECT SUMMARY A CRITICAL HURDLE TO FURTHER IMPROVING THE QUALITY OF LIFE FOR PEOPLE | $506,550 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | COMPARTMENTALIZATION AND DISCRIMINATION OF DSRNA IN THE NUCLEUS - PROJECT SUMMARY THE LONG-TERM GOAL OF OUR LAB IS TO UNDERSTAND THE FUNDAMENTAL MECHANISMS BY | $506,550 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CROSS-SECTIONAL STUDY TO IDENTIFY HOST PLASMA BIOMARKERS AND SOMALOGIC DISEASE PROGNOSIS SCORES ASSOCIATED WITH CELLULAR HIV-1 RNA EXPRESSION IN ART SUPPRESSED | $506,550 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | MYELOID CELL-DERIVED INTERLEUKIN 1B PROMOTES CHEMORESISTANCE IN METASTATIC OVARIAN CANCER - PROJECT SUMMARY MOST OVARIAN CANCER (OC) PATIENTS RESPOND TO THE FRO | $473,624 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | METABOLIC AND MOLECULAR REGULATION OF MYELOID CELL FUNCTIONS IN BRAIN CANCER - GLIOBLASTOMA (GBM), THE MOST AGGRESSIVE AND LETHAL FORM OF BRAIN CANCER, IS CHARA | $471,604 |
| 2026 | National Science Foundation | Grant or other assistance | BIOLOGICAL SCIENCES 47.074 | REU SITE: MOLECULAR BASIS OF CELLULAR PHENOTYPES (MBCP) -THIS REU SITE AWARD TO THE WISTAR INSTITUTE, AN INDEPENDENT BIOMEDICAL RESEARCH INSTITUTE LOCATED IN PH | $465,318 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | PERIPHERAL MEMBRANE PROTEINS AND DISEASE: TOOL DEVELOPMENT, BASIC INVESTIGATIONS, AND INHIBITOR DESIGN - ABSTRACT PERIPHERAL MEMBRANE PROTEINS (PMPS) REPRESENT | $442,879 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | FUNCTIONAL ANALYSIS OF P53 POLYMORPHIC VARIANTS | $433,100 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHROMATIN DYNAMICS OF KSHV LATENCY | $410,175 |
| 2026 | National Institutes of Health | Grant or other assistance | MEDICAL LIBRARY ASSISTANCE 93.879 | COMPUTATIONAL METHODS FOR DISCOVERY OF DISEASE-MODULATING MICROBIAL GENES - ABSTRACT MICROBIAL GENES IN GUT AND DISEASED TISSUES WERE RECENTLY LINKED WITH PROGR | $408,771 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THE GENETICS OF TUMOR SUPPRESSION BY P53 - PROJECT SUMMARY THIS SUBMISSION REPRESENTS A COLLABORATIVE APPLICATION FROM MAUREEN MURPHY PHD AT THE WISTAR INSTITUT | $401,611 |
| 2026 | National Science Foundation | Grant or other assistance | STEM EDUCATION (FORMERLY EDUCATION AND HUMAN RESOURCES) 47.076 | SCALING PROJECT-BASED, AUTHENTIC RESEARCH AND KNOWLEDGE IN LIFE SCIENCE INNOVATION -THIS PROJECT AIMS TO SERVE THE NATIONAL INTEREST BY EXPANDING ACCESS TO PROJ | $399,460 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | CHROMATIN REGULATION OF THE EPSTEIN-BARR VIRUS LATENCY | $364,600 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | THE ROLE OF NON-CANONICAL NUCLEIC ACID STRUCTURES IN GENOME REGULATION - PROJECT SUMMARY NUCLEAR PROCESSES SUCH AS TRANSCRIPTION, REPLICATION, AND REPAIR DISRUP | $363,191 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TRAINING PROGRAM IN BASIC CANCER RESEARCH | $352,132 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | NANOBODIES AGAINST LYMPHOCYTE ACTIVATION GENE 3 FOR INFLAMMATION REGULATION AND CANCER IMMUNOTHERAPY - PROJECT SUMMARY/ABSTRACT LYMPHOCYTE ACTIVATION GENE 3 (LA | $281,620 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | INTERROGATING IMMUNOMODULATION FOR ANTI-METASTATIC THERAPY - PROJECT SUMMARY THIS PROPOSAL OUTLINES A FIVE-YEAR CAREER DEVELOPMENT PROGRAM FOR CHRIS MCGINNIS, | $249,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | REPROGRAMMING T CELL FUNCTION WITH MULTIPLEXED GENOME ENGINEERING TO DEVELOP NEXT-GENERATION IMMUNOTHERAPY - ADOPTIVE CELLULAR IMMUNOTHERAPY HAS REVOLUTIONIZED | $249,000 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | EPIGENETIC REPROGRAMMING TO TARGET SENESCENT OVARIAN CANCER CELLS AND OVERCOME THERAPEUTIC RESISTANCE FEB 4, 2026, MOD 1 TRANSFERRED AWARD TO WISTAR INSTITUTE M | $243,769 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ADVANCING CANCER RESEARCH THROUGH COMPREHENSIVE PROTEOMICS AND METABOLOMICS ANALYSES | $237,136 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTEGRATIVE APPROACH TO COMPREHENSIVE ANALYSIS OF HIGH THROUGHPUT DATA ON A CANCER CENTER LEVEL | $193,456 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DEFINING THE SINGLE-CELL EPIGENETIC LANDSCAPE OF THE HIV-1 RESERVOIR FOR EFFECTIVE LATENCY REVERSAL - PROJECT SUMMARY/ABSTRACT WHILE THE ADVENT OF ANTIRETROVIRA | $162,000 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | HOST GLYCOMIC MODULATION OF HIV-ASSOCIATED NEURO-INFLAMMATION DURING VIRAL SUPPRESSION | -$196,012 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | BEAT-HIV: DELANEY COLLABORATORY TO CURE HIV-1 INFECTION BY COMBINATION IMMUNOTHERAPY - SUMMARY CURRENT HIV CURATIVE STRATEGIES HAVE PROVEN INSUFFICIENT TO ERADI | $5,626,081 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INDIVIDUALIZED HIV CURATIVE COMBINATION STRATEGY AGAINST PERSISTENT HIV ON ART - SUMMARY WE HAVE DEMONSTRATED MULTIPLE LINES OF EVIDENCE SUPPORTING THE ROLE FOR | $3,568,644 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | CONSOLIDATED BASIC CANCER RESEARCH PROGRAM | $2,833,735 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | SYNTHETIC DNA-LAUNCHED AND ADJUVANTED ENV IMMUNOGENS FOR HIV - OVERALL SUMMARY A PROTECTIVE VACCINE FOR HIV IS ARGUABLY THE MOST IMPORTANT PREVENTION STRATEGY T | $2,424,072 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING THE EPIGENETIC AND METABOLIC CONTROL OF EBV-EPITHELIAL CANCERS - OVERALL – PROJECT SUMMARY THE OVERALL AIM OF THIS NEW PROGRAM PROJECT (P01) PROPOSAL | $2,420,381 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | SPORE IN SKIN CANCER - PROJECT SUMMARY – OVERALL THIS WISTAR/UPENN SKIN SPORE REPRESENTS A HIGHLY SUCCESSFUL AND LONGSTANDING COLLABORATION. IMMUNE CHECKPOINT I | $2,351,294 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | RATIONAL APPROACHES TO MELANOMA THERAPY | $1,284,372 |
| 2025 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | MANIPULATING EPITOPE IMMUNODOMINANCE AND TRACKING B-CELL-ANTIGEN INTERACTIONS FOR VACCINE DESIGN. - PROJECT SUMMARY/ ABSTRACT INFECTIOUS DISEASES ARE SERIOUS AN | $1,105,200 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | IMMUNOTHERAPEUTIC TARGETING OF SLC39A9 IN CDKN2A-LOW MELANOMA | $1,101,574 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING S6K2 TO OVERCOME DRUG RESISTANCE IN NRAS-MUTANT MELANOMA - PROJECT SUMMARY WHILE SEVERAL THERAPIES HAVE BEEN APPROVED FOR MELANOMA, THERE ARE LIMITED | $977,758 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | STRUCTURAL VACCINOLOGY GUIDED DEVELOPMENT OF A UNIVERSAL COV VACCINE UTILIZING NUCLEIC ACID DELIVERED NANOPARTICLES - PROJECT SUMMARY IN DECEMBER 2019 A NOVEL C | $890,878 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INVESTIGATION INTO THE ACTIVATION OF MULTIPLE BNAB PRECURSORS USING STRUCTURE-DESIGNED IMMUNOGENS AND IG KNOCK-IN MICE - PROJECT SUMMARY HIV-1 VACCINES THAT CAN | $881,947 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DRUGGING EBNA1 TO TREAT EBV-ASSOCIATED CANCERS - PROJECT SUMMARY EBV LATENT INFECTION IS RESPONSIBLE FOR ~200,000 NEW CANCERS PER YEAR. TO DATE, THERE ARE NO EB | $717,335 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THERAPEUTIC TARGETING MDSC-MEDIATED IMMUNE SUPPRESSION IN CANCER - PROJECT SUMMARY THE PROMINENT CHANGE IN THE MYELOID COMPARTMENT IN CANCER IS THE EXPANSION OF | $696,515 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REGULATION OF GENE EXPRESSION BY ALTERNATIVE POLYADENYLATION - PROJECT SUMMARY MOST MAMMALIAN GENES HARBOR MULTIPLE CLEAVAGE AND POLYADENYLATION SITES, OR PASS, | $664,842 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF AFRICAN-CENTRIC TP53 VARIANT IN HIGHER H. PYLORI PREVALENCE IN AFRICAN AMERICANS - PROJECT SUMMARY AFRICAN AMERICANS HAVE A 6-FOLD HIGHER H. PYLORI (HP) | $600,349 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TRANSCRIPTIONAL REPROGRAMMING IN MELANOMA PLASTICITY - PROJECT SUMMARY/ABSTRACT THIS APPLICATION FOCUSES ON ADVANCED MELANOMA, A HIGHLY AGGRESSIVE TYPE OF SKIN | $594,386 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHARACTERIZING THE SOURCES, MECHANISMS, AND TRANSLATIONAL RELEVANCE OF MICROBIAL TMAO IN DRIVING ANTI-TUMOR IMMUNITY IN PANCREATIC CANCER. - PROJECT SUMMARY THE | $566,752 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DEVELOPING POTENT HIV-SPECIFIC CAR T CELLS THROUGH OPTIMIZING ANTIGEN SENSITIVITY - PROJECT SUMMARY GIVEN THE INABILITY OF THE IMMUNE RESPONSE TO CONSISTENTLY S | $558,595 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTERROGATING TYPE I INTERFERON SIGNALING IN BREAST CANCER BRAIN METASTASIS - PROJECT SUMMARY THE BRAIN IS ONE OF THE COMMON ORGANS FOR BREAST CANCER RECURRENCE | $546,142 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DESIGN OF THE FIRST MDM2 TARGETING PROTACS FOR TREATMENT OF P53 MUTANT OR DEFICIENT CANCERS - PROJECT SUMMARY / ABSTRACT OUR PROPOSAL FOCUSES ON THE DEVELOPMENT | $544,697 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REMODELING OF THE HOST EPIGENOME DURING EBV INFECTION - PROJECT SUMMARY IN EBV+ LYMPHOMAS VIRAL PROTEIN EXPRESSION IS THE ONCOGENIC DRIVER AND PROGRESSIVE FORCE | $543,298 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REGULATION OF VIRAL CHROMATIN ARCHITECTURE DURING EBV LATENCY | $541,989 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | EBNA1 INHIBITOR FOR TREATMENT OF EBV-POSITIVE DLBCL - PROJECT SUMMARY THE EPSTEIN-BARR VIRUS (EBV) IS RESPONSIBLE FOR APPROXIMATELY 200,000 NEW CANCER CASES EAC | $534,316 |
| 2025 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | CTCF-DEPENDENT MECHANISMS OF ATRX IN NEURONAL DIFFERENTIATION - PROJECT SUMMARY ATRX IS AN EPIGENETIC FACTOR THAT IS MUTATED IN ATRX SYNDROME. ATRX IS REQUIRED | $530,646 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | NEW CONTROL OF ONCOGENE ACTIVATION IN T-CELL LEUKEMIA - PROJECT SUMMARY/ABSTRACT NOTCH1 SIGNALING IS AN IMPORTANT MEDIATOR OF STEM CELL SELF-RENEWAL AND THERAPE | $525,427 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | PARKIN TUMOR SUPPRESSION - PROJECT SUMMARY THE LOSS OF ENDOGENOUS TUMOR SUPPRESSORS IS AN OBLIGATORY STEP IN TUMOR ONSET AND PROGRESSION, BUT THE UNDERLYING MEC | $499,626 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TRAINING PROGRAM IN BASIC CANCER RESEARCH | $489,395 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | FUNCTIONAL ANALYSIS OF P53 POLYMORPHIC VARIANTS | $487,219 |
| 2025 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | METABOLIC AND MOLECULAR REGULATION OF MYELOID CELL FUNCTIONS IN BRAIN CANCER - GLIOBLASTOMA (GBM), THE MOST AGGRESSIVE AND LETHAL FORM OF BRAIN CANCER, IS CHARA | $473,753 |
| 2025 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | R-LOOP FUNCTIONS IN NEURONAL GENE EXPRESSION AND GENOME ORGANIZATION - PROJECT SUMMARY THE GOAL OF THIS PROPOSAL IS TO UNCOVER THE MECHANISTIC CONNECTION BETWEE | $464,093 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REGULATION OF EBV LATENCY BY PURINE METABOLISM AND SIGNALING - EPSTEIN-BARR VIRUS (EBV) REPROGRAMS HOST CELL GENE EXPRESSION AND METABOLISM DURING THE ESTABLISH | $457,575 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | IMMUNOTHERAPEUTIC TARGETING OF SLC39A9 IN CDKN2A-LOW MELANOMA | $442,557 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | CONTROL OF TELOMERE HETEROCHROMATIN BY TERRA | $434,696 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ROLE OF UVRAG-MEDIATED AUTOPHAGY IN TUMOR SUPPRESSION | $434,696 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ADNP MECHANISMS IN R-LOOP REGULATION DURING DIFFERENTIATION - PROJECT SUMMARY ABERRATIONS IN CHROMATIN STRUCTURE CAN BE A CAUSAL MECHANISM OF NUMEROUS HUMAN DIS | $425,640 |
| 2025 | National Institutes of Health | Grant or other assistance | MEDICAL LIBRARY ASSISTANCE 93.879 | COMPUTATIONAL METHODS FOR DISCOVERY OF DISEASE-MODULATING MICROBIAL GENES - ABSTRACT MICROBIAL GENES IN GUT AND DISEASED TISSUES WERE RECENTLY LINKED WITH PROGR | $412,712 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHROMATIN DYNAMICS OF KSHV LATENCY | $410,175 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THE GENETICS OF TUMOR SUPPRESSION BY P53 - PROJECT SUMMARY THIS SUBMISSION REPRESENTS A COLLABORATIVE APPLICATION FROM MAUREEN MURPHY PHD AT THE WISTAR INSTITUT | $401,611 |
| 2025 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | CHROMATIN REGULATION OF THE EPSTEIN-BARR VIRUS LATENCY | $364,600 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | REPROGRAMMING T CELL FUNCTION WITH MULTIPLEXED GENOME ENGINEERING TO DEVELOP NEXT-GENERATION IMMUNOTHERAPY - ADOPTIVE CELLULAR IMMUNOTHERAPY HAS REVOLUTIONIZED | $249,000 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTEGRATED ANALYSES OF THE EPIGENOME TO UNDERSTAND THE MOLECULAR BASIS OF HEMATOPOIETIC MALIGNANCIES - PROJECT SUMMARY RESEARCH PLAN: AN IMPAIRED HEMATOPOIETIC | $249,000 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ADVANCING CANCER RESEARCH THROUGH COMPREHENSIVE PROTEOMICS AND METABOLOMICS ANALYSES | $237,136 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTEGRATIVE APPROACH TO COMPREHENSIVE ANALYSIS OF HIGH THROUGHPUT DATA ON A CANCER CENTER LEVEL | $150,262 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TUMOR PLASTICITY | $0 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | MODELING CANCER EVOLUTION FOR PREDICTION WITH NEURAL NETWORKS: METHODS AND APPLICATIONS - PROJECT SUMMARY/ABSTRACT THE STUDY OF TUMOR EVOLUTION CAN UNCOVER EVE | -$30,552 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ANALYSIS OF MRNA POLYADENYLATION ACROSS SPECIES AND TISSUES | -$135,686 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | BEAT-HIV: DELANEY COLLABORATORY TO CURE HIV-1 INFECTION BY COMBINATION IMMUNOTHERAPY | -$962,506 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | BEAT-HIV: DELANEY COLLABORATORY TO CURE HIV-1 INFECTION BY COMBINATION IMMUNOTHERAPY - SUMMARY CURRENT HIV CURATIVE STRATEGIES HAVE PROVEN INSUFFICIENT TO ERADI | $5,736,593 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | SYNTHETIC DNA-LAUNCHED AND ADJUVANTED ENV IMMUNOGENS FOR HIV - OVERALL SUMMARY A PROTECTIVE VACCINE FOR HIV IS ARGUABLY THE MOST IMPORTANT PREVENTION STRATEGY T | $4,420,687 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | CONSOLIDATED BASIC CANCER RESEARCH PROGRAM | $3,583,734 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING THE EPIGENETIC AND METABOLIC CONTROL OF EBV-EPITHELIAL CANCERS - OVERALL – PROJECT SUMMARY THE OVERALL AIM OF THIS NEW PROGRAM PROJECT (P01) PROPOSAL | $2,286,821 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | SPORE IN SKIN CANCER - PROJECT SUMMARY – OVERALL THIS WISTAR/UPENN SKIN SPORE REPRESENTS A HIGHLY SUCCESSFUL AND LONGSTANDING COLLABORATION. IMMUNE CHECKPOINT I | $2,257,242 |
| 2024 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | TARGETING RESIDENT MACROPHAGES TO TREAT METASTATIC OVARIAN CANCER | $1,320,225 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | RATIONAL APPROACHES TO MELANOMA THERAPY | $1,220,153 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INVESTIGATION INTO THE ACTIVATION OF MULTIPLE BNAB PRECURSORS USING STRUCTURE-DESIGNED IMMUNOGENS AND IG KNOCK-IN MICE - PROJECT SUMMARY HIV-1 VACCINES THAT CAN | $1,007,726 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GLYCOMIC MODULATION OF GUT MICROBIOME DURING HIV INFECTION | $802,821 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REGULATION OF GENE EXPRESSION BY ALTERNATIVE POLYADENYLATION - PROJECT SUMMARY MOST MAMMALIAN GENES HARBOR MULTIPLE CLEAVAGE AND POLYADENYLATION SITES, OR PASS, | $715,492 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DRUGGING EBNA1 TO TREAT EBV-ASSOCIATED CANCERS - PROJECT SUMMARY EBV LATENT INFECTION IS RESPONSIBLE FOR ~200,000 NEW CANCERS PER YEAR. TO DATE, THERE ARE NO EB | $682,335 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | TARGETING SIGLEC-9/SIALOGLYCAN INTERACTIONS TO ENHANCE NK FUNCTIONS DURING HIV INFECTION - PROJECT SUMMARY: THE FUNCTIONS OF NATURAL KILLER (NK) CELLS CAN BE IN | $678,302 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THERAPEUTIC TARGETING MDSC-MEDIATED IMMUNE SUPPRESSION IN CANCER - PROJECT SUMMARY THE PROMINENT CHANGE IN THE MYELOID COMPARTMENT IN CANCER IS THE EXPANSION OF | $661,690 |
| 2024 | National Science Foundation | Grant or other assistance | STEM EDUCATION (FORMERLY EDUCATION AND HUMAN RESOURCES) 47.076 | TRI-STATE EXPANSION, CURRICULUM EVOLUTION, AND EQUITY DURING BIOTECHNICIAN TRAINING (TRI EXCEED BTT) -THE GROWTH OF THE LIFE SCIENCE INDUSTRY, FUELED BY CELL AN | $649,971 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TRANSCRIPTIONAL REPROGRAMMING IN MELANOMA PLASTICITY - PROJECT SUMMARY/ABSTRACT THIS APPLICATION FOCUSES ON ADVANCED MELANOMA, A HIGHLY AGGRESSIVE TYPE OF SKIN | $614,911 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHARACTERIZING THE SOURCES, MECHANISMS, AND TRANSLATIONAL RELEVANCE OF MICROBIAL TMAO IN DRIVING ANTI-TUMOR IMMUNITY IN PANCREATIC CANCER. - PROJECT SUMMARY THE | $587,277 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF AFRICAN-CENTRIC TP53 VARIANT IN HIGHER H. PYLORI PREVALENCE IN AFRICAN AMERICANS - PROJECT SUMMARY AFRICAN AMERICANS HAVE A 6-FOLD HIGHER H. PYLORI (HP) | $576,336 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DEVELOPING POTENT HIV-SPECIFIC CAR T CELLS THROUGH OPTIMIZING ANTIGEN SENSITIVITY - PROJECT SUMMARY GIVEN THE INABILITY OF THE IMMUNE RESPONSE TO CONSISTENTLY S | $558,595 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | TRAINING PROGRAM IN BASIC CANCER RESEARCH | $558,485 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REMODELING OF THE HOST EPIGENOME DURING EBV INFECTION - PROJECT SUMMARY IN EBV+ LYMPHOMAS VIRAL PROTEIN EXPRESSION IS THE ONCOGENIC DRIVER AND PROGRESSIVE FORCE | $553,298 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | A CANCER-DERIVED TRUNCATING MUTATION IN DISEASE PENETRANCE AND PROGRESSION OF MSI CRC | $548,526 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REGULATION OF VIRAL CHROMATIN ARCHITECTURE DURING EBV LATENCY | $541,989 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTERROGATING TYPE I INTERFERON SIGNALING IN BREAST CANCER BRAIN METASTASIS - PROJECT SUMMARY THE BRAIN IS ONE OF THE COMMON ORGANS FOR BREAST CANCER RECURRENCE | $529,002 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DESIGN OF THE FIRST MDM2 TARGETING PROTACS FOR TREATMENT OF P53 MUTANT OR DEFICIENT CANCERS - PROJECT SUMMARY / ABSTRACT OUR PROPOSAL FOCUSES ON THE DEVELOPMENT | $515,157 |
| 2024 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | CTCF-DEPENDENT MECHANISMS OF ATRX IN NEURONAL DIFFERENTIATION - PROJECT SUMMARY ATRX IS AN EPIGENETIC FACTOR THAT IS MUTATED IN ATRX SYNDROME. ATRX IS REQUIRED | $514,726 |
| 2024 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | R-LOOP FUNCTIONS IN NEURONAL GENE EXPRESSION AND GENOME ORGANIZATION - PROJECT SUMMARY THE GOAL OF THIS PROPOSAL IS TO UNCOVER THE MECHANISTIC CONNECTION BETWEE | $506,972 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | EBNA1 INHIBITOR FOR TREATMENT OF EBV-POSITIVE DLBCL - PROJECT SUMMARY THE EPSTEIN-BARR VIRUS (EBV) IS RESPONSIBLE FOR APPROXIMATELY 200,000 NEW CANCER CASES EAC | $505,631 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | PARKIN TUMOR SUPPRESSION - PROJECT SUMMARY THE LOSS OF ENDOGENOUS TUMOR SUPPRESSORS IS AN OBLIGATORY STEP IN TUMOR ONSET AND PROGRESSION, BUT THE UNDERLYING MEC | $499,626 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | NEW CONTROL OF ONCOGENE ACTIVATION IN T-CELL LEUKEMIA - PROJECT SUMMARY/ABSTRACT NOTCH1 SIGNALING IS AN IMPORTANT MEDIATOR OF STEM CELL SELF-RENEWAL AND THERAPE | $492,814 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | REGULATION OF TUMOR RECURRENCE BY STRESS ACTIVATED NEUTROPHILS | $489,730 |
| 2024 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | IMMUNOMODULATORY ROLE OF ACETATE METABOLISM IN BREAST CANCER MOD P00001 INCORPORATES TRANSFER OF AWARD | $464,925 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING S6K2 TO OVERCOME DRUG RESISTANCE IN NRAS-MUTANT MELANOMA - PROJECT SUMMARY WHILE SEVERAL THERAPIES HAVE BEEN APPROVED FOR MELANOMA, THERE ARE LIMITED | $464,112 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | FUNCTIONAL ANALYSIS OF P53 POLYMORPHIC VARIANTS | $462,079 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REGULATION OF EBV LATENCY BY PURINE METABOLISM AND SIGNALING - EPSTEIN-BARR VIRUS (EBV) REPROGRAMS HOST CELL GENE EXPRESSION AND METABOLISM DURING THE ESTABLISH | $457,575 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THE GENETICS OF TUMOR SUPPRESSION BY P53 - PROJECT SUMMARY THIS SUBMISSION REPRESENTS A COLLABORATIVE APPLICATION FROM MAUREEN MURPHY PHD AT THE WISTAR INSTITUT | $454,267 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ADNP MECHANISMS IN R-LOOP REGULATION DURING DIFFERENTIATION - PROJECT SUMMARY ABERRATIONS IN CHROMATIN STRUCTURE CAN BE A CAUSAL MECHANISM OF NUMEROUS HUMAN DIS | $425,640 |
| 2024 | National Institutes of Health | Grant or other assistance | MEDICAL LIBRARY ASSISTANCE 93.879 | COMPUTATIONAL METHODS FOR DISCOVERY OF DISEASE-MODULATING MICROBIAL GENES - ABSTRACT MICROBIAL GENES IN GUT AND DISEASED TISSUES WERE RECENTLY LINKED WITH PROGR | $425,531 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THE IMPACT OF CODING REGION VARIANTS ON MUTANT P53 BIOLOGY | $422,619 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | CONTROL OF TELOMERE HETEROCHROMATIN BY TERRA | $412,961 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ROLE OF UVRAG-MEDIATED AUTOPHAGY IN TUMOR SUPPRESSION | $412,961 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | CHROMATIN DYNAMICS OF KSHV LATENCY | $410,175 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | UNDERSTANDING PPARGAMMA SIGNALING IN MELANOMA BRAIN METASTASIS | $387,081 |
| 2024 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | CHROMATIN REGULATION OF THE EPSTEIN-BARR VIRUS LATENCY | $357,308 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DSRNA PRODUCTION AND SENSING DURING DNA VIRUS INFECTION - PROJECT SUMMARY VIRAL INFECTIONS ARE KNOWN TO PRODUCE DOUBLE-STRANDED RNA (DSRNA), A MOLECULE THAT IS | $249,167 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTEGRATED ANALYSES OF THE EPIGENOME TO UNDERSTAND THE MOLECULAR BASIS OF HEMATOPOIETIC MALIGNANCIES - PROJECT SUMMARY RESEARCH PLAN: AN IMPAIRED HEMATOPOIETIC | $249,000 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ADVANCING CANCER RESEARCH THROUGH COMPREHENSIVE PROTEOMICS AND METABOLOMICS ANALYSES | $237,136 |
| 2024 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | METABOLIC AND MOLECULAR REGULATION OF MYELOID CELL FUNCTIONS IN BRAIN CANCER - GLIOBLASTOMA (GBM), THE MOST AGGRESSIVE AND LETHAL FORM OF BRAIN CANCER, IS CHARA | $233,071 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | INTEGRATIVE APPROACH TO COMPREHENSIVE ANALYSIS OF HIGH THROUGHPUT DATA ON A CANCER CENTER LEVEL | $150,262 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | BEAT-HIV: DELANEY COLLABORATORY TO CURE HIV-1 INFECTION BY COMBINATION IMMUNOTHERAPY | $0 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | EPIGENETIC PATHWAYS IN ATRX-MEDIATED CTCF REGULATION - PROJECT SUMMARY ATRX IS A CHROMATIN REMODELER WITH DIVERSE AND ESSENTIAL ROLES IN GENE REGULATION AND GEN | $0 |
| 2024 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | REGULATION OF MYELOMA PROGRESSION BY PROTEIN CITRULLINATION | -$621 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | STRUCTURE AND FUNCTION OF DSRNA ADENOSINE DEAMINASE | -$1,999 |
| 2024 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | THE MULTIFACETED ROLE OF ACETATE IN CANCER | -$7,068 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | NEGATIVE REGULATION OF MYELOID-DERIVED SUPPRESSIVE CELLS IN CANCER | -$43,351 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | STRESS RESPONSE FUNCTIONS OF ADAR1 REGULATED BY MAP KINASES | -$61,983 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | INTEGRATION OF BIOMARKER SIGNATURES FROM PERIPHERAL BLOOD FOR DIAGNOSIS, PROGNOSIS, REMISSION AND RECURRENCE OF LUNG CANCER | -$67,026 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | BEAT-HIV: DELANEY COLLABORATORY TO CURE HIV-1 INFECTION BY COMBINATION IMMUNOTHERAPY - SUMMARY CURRENT HIV CURATIVE STRATEGIES HAVE PROVEN INSUFFICIENT TO ERADI | $5,780,735 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | SYNTHETIC DNA-LAUNCHED AND ADJUVANTED ENV IMMUNOGENS FOR HIV - OVERALL SUMMARY A PROTECTIVE VACCINE FOR HIV IS ARGUABLY THE MOST IMPORTANT PREVENTION STRATEGY T | $4,497,948 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | CONSOLIDATED BASIC CANCER RESEARCH PROGRAM | $2,964,875 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETED THERAPIES IN MELANOMA | $2,478,587 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING THE EPIGENETIC AND METABOLIC CONTROL OF EBV-EPITHELIAL CANCERS - OVERALL – PROJECT SUMMARY THE OVERALL AIM OF THIS NEW PROGRAM PROJECT (P01) PROPOSAL | $2,436,054 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | SPORE IN SKIN CANCER - PROJECT SUMMARY – OVERALL THIS WISTAR/UPENN SKIN SPORE REPRESENTS A HIGHLY SUCCESSFUL AND LONGSTANDING COLLABORATION. IMMUNE CHECKPOINT I | $2,186,705 |
| 2023 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | EFFECTS OF MU-OPIATE RECEPTOR ENGAGEMENT ON MICROBIAL TRANSLOCATION AND RESIDUAL IMMUNE ACTIVATION IN HIV-INFECTED, ART SUPPRESSED OPIOID USE DISORDER PATENTS I | $1,621,237 |
| 2023 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | DEVELOPING RATIONAL APPROACHES FOR ACRAL MELANOMA | $1,194,425 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TUMOR PLASTICITY | $1,117,200 |
| 2023 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | EPSTEIN-BARR VIRUS-DRIVEN B-CELL INFLAMMATION AND CNS TRAFFICKING IN MS | $999,006 |
| 2023 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | HOST GLYCOMIC MODULATION OF HIV-ASSOCIATED NEURO-INFLAMMATION DURING VIRAL SUPPRESSION | $843,815 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INVESTIGATION INTO THE ACTIVATION OF MULTIPLE BNAB PRECURSORS USING STRUCTURE-DESIGNED IMMUNOGENS AND IG KNOCK-IN MICE - PROJECT SUMMARY HIV-1 VACCINES THAT CAN | $843,126 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GLYCOMIC MODULATION OF GUT MICROBIOME DURING HIV INFECTION | $815,931 |
| 2023 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | EFFECTS OF MU-OPIATE RECEPTOR ENGAGEMENT ON THE PERSISTENCE OF HIV-ASSOCIATED ACTIVATION AND VIRAL RESERVOIRS IN INDIVIDUALS RECEIVING MEDICATION ASSISTED TREAT | $766,227 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | EBNA1 INHIBITOR FOR TREATMENT OF EBV-POSITIVE DLBCL - PROJECT SUMMARY THE EPSTEIN-BARR VIRUS (EBV) IS RESPONSIBLE FOR APPROXIMATELY 200,000 NEW CANCER CASES EAC | $745,842 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DRUGGING EBNA1 TO TREAT EBV-ASSOCIATED CANCERS - PROJECT SUMMARY EBV LATENT INFECTION IS RESPONSIBLE FOR ~200,000 NEW CANCERS PER YEAR. TO DATE, THERE ARE NO EB | $706,598 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THERAPEUTIC TARGETING MDSC-MEDIATED IMMUNE SUPPRESSION IN CANCER - PROJECT SUMMARY THE PROMINENT CHANGE IN THE MYELOID COMPARTMENT IN CANCER IS THE EXPANSION OF | $682,585 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER CENTERS SUPPORT GRANTS 93.397 | RATIONAL APPROACHES TO MELANOMA THERAPY | $635,508 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | REGULATION OF NEONATAL INFLAMMATION BY MYELOID-DERIVED SUPPRESSOR CELLS | $634,964 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | TARGETING SIGLEC-9/SIALOGLYCAN INTERACTIONS TO ENHANCE NK FUNCTIONS DURING HIV INFECTION - PROJECT SUMMARY: THE FUNCTIONS OF NATURAL KILLER (NK) CELLS CAN BE IN | $633,402 |
| 2023 | National Institutes of Health | Grant or other assistance | ENVIRONMENTAL HEALTH 93.113 | MOLECULAR MECHANISM OF UV PROTECTION IN CUTANEOUS MELANOMA | $622,335 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF AFRICAN-CENTRIC TP53 VARIANT IN HIGHER H. PYLORI PREVALENCE IN AFRICAN AMERICANS - PROJECT SUMMARY AFRICAN AMERICANS HAVE A 6-FOLD HIGHER H. PYLORI (HP) | $600,349 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ANALYSIS OF MRNA POLYADENYLATION ACROSS SPECIES AND TISSUES | $563,262 |
| 2023 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | CTCF-DEPENDENT MECHANISMS OF ATRX IN NEURONAL DIFFERENTIATION - PROJECT SUMMARY ATRX IS AN EPIGENETIC FACTOR THAT IS MUTATED IN ATRX SYNDROME. ATRX IS REQUIRED | $530,646 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DESIGN OF THE FIRST MDM2 TARGETING PROTACS FOR TREATMENT OF P53 MUTANT OR DEFICIENT CANCERS - PROJECT SUMMARY / ABSTRACT OUR PROPOSAL FOCUSES ON THE DEVELOPMENT | $529,097 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | A CANCER-DERIVED TRUNCATING MUTATION IN DISEASE PENETRANCE AND PROGRESSION OF MSI CRC | $526,382 |
| 2023 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | SIALIC ACID MODULATION OF HIV-ASSOCIATED CHRONIC INFLAMMAGING | $504,311 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | NEW CONTROL OF ONCOGENE ACTIVATION IN T-CELL LEUKEMIA - PROJECT SUMMARY/ABSTRACT NOTCH1 SIGNALING IS AN IMPORTANT MEDIATOR OF STEM CELL SELF-RENEWAL AND THERAPE | $504,152 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | TARGETING S6K2 TO OVERCOME DRUG RESISTANCE IN NRAS-MUTANT MELANOMA - PROJECT SUMMARY WHILE SEVERAL THERAPIES HAVE BEEN APPROVED FOR MELANOMA, THERE ARE LIMITED | $475,922 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REGULATION OF EBV LATENCY BY PURINE METABOLISM AND SIGNALING - EPSTEIN-BARR VIRUS (EBV) REPROGRAMS HOST CELL GENE EXPRESSION AND METABOLISM DURING THE ESTABLISH | $457,575 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ROLE OF AN INTEGRATOR-EGR AXIS IN THE REGULATION OF MYELOID ENHANCERS | $446,500 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THE IMPACT OF CODING REGION VARIANTS ON MUTANT P53 BIOLOGY | $435,965 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | FUNCTIONAL ANALYSIS OF P53 POLYMORPHIC VARIANTS | $434,908 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ROLE OF UVRAG-MEDIATED AUTOPHAGY IN TUMOR SUPPRESSION | $434,696 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | CONTROL OF TELOMERE HETEROCHROMATIN BY TERRA | $434,696 |
| 2023 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | DECIPHERING BRAIN STROMA-REGULATED IMMUNE MICROENVIRONMENT IN MELANOMA BRAIN METASTASIS MOD P00001 INCORPORATED TRANSFER OF AWARD TO INSTITUTE FOR CANCER RESEAR | $432,260 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ADNP MECHANISMS IN R-LOOP REGULATION DURING DIFFERENTIATION - PROJECT SUMMARY ABERRATIONS IN CHROMATIN STRUCTURE CAN BE A CAUSAL MECHANISM OF NUMEROUS HUMAN DIS | $425,640 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THE GENETICS OF TUMOR SUPPRESSION BY P53 - PROJECT SUMMARY THIS SUBMISSION REPRESENTS A COLLABORATIVE APPLICATION FROM MAUREEN MURPHY PHD AT THE WISTAR INSTITUT | $422,186 |
State business registration
- THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY PA, Employee benefit plan sponsor (Form 5500), Filed for plan year 2025
The same business name in the same state, from the state’s official registry data.
Patents
96 US patents filed in the last 20 years.
- The Wistar Institute of Anatomy and Biology 96 patents, 2012-01-31 to 2026-08-04 EXACT high confidence: identical full name and state
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12697298 | Optimized synthetic consensus immunogenic compositions targeting fibroblast activation protein | 2026-08-04 | PTBLXML, file of 2026-08-04 |
| US 12662518 | Engineered peptide and peptide mimetic compositions and methods | 2026-06-23 | PTBLXML, file of 2026-06-23 |
| US 12629364 | Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs | 2026-05-19 | PTBLXML, file of 2026-05-19 |
| US 12617841 | Nucleic acid antibody constructs for use against respiratory syncytial virus | 2026-05-05 | PTBLXML, file of 2026-05-05 |
| US 12606612 | Multivalent DNA antibody constructs and use thereof | 2026-04-21 | PTBLXML, file of 2026-04-21 |
| US 12582643 | Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy | 2026-03-24 | PTBLXML, file of 2026-03-24 |
| US 12576144 | Vaccines against Powassan virus, and methods of using same | 2026-03-17 | PTBLXML, file of 2026-03-17 |
| US 12564628 | Epstein-BARR virus nucleic acid constructs and vaccines made therefrom, and methods of using same | 2026-03-03 | PTBLXML, file of 2026-03-03 |
| US 12559547 | Multivalent DNA antibody constructs and use thereof | 2026-02-24 | PTBLXML, file of 2026-02-24 |
| US 12492243 | DNA antibody constructs for use against Pseudomonas aeruginosa | 2025-12-09 | PVGPATDIS, file of 2026-04-10 |
The newest patents of the PatentsView assignees above, matched to this record by name (and state).
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY | PA | Form 5500 (employee benefit plans) | EIN (EXACT) |
Matched by name (and state) or EIN only; a shared name is not proof of the same person or organization.
Comments